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REGULATION OF IMMUNE RESPONSES BY RasGEF1B CIRCULAR RNA 
ABSTRACT 
Circular RNAs (circRNAs) constitute a large class of RNA species formed by 
the back-splicing of co-linear exons, often within protein-coding transcripts. Despite 
much progress in the field, it remains elusive whether the majority of circRNAs are 
merely aberrant splicing by-products with unknown functions, or their production is 
spatially and temporally regulated to carry out specific biological functions. To date, the 
majority of circRNAs have been cataloged in resting cells. Here, this research identifies 
a LPS-inducible circRNA: mcircRasGEF1B, which is predominantly localized in 
cytoplasm, shows cell-type specific expression, and has a human homolog with similar 
properties, hcircRasGEF1B. The functional experiments show that knockdown of the 
expression of mcircRasGEF1B reduces LPS-induced ICAM-1 expression. Additionally, 
this study demonstrates that mcircRasGEF1B regulates the stability of mature ICAM-1 
mRNAs. To gain broader insights of mcircRasGEF1B function during cellular response 
to LPS stimulation, targeted mcircRasGEF1B depletion with high-throughput 
transcriptomic analysis is combined. The results show that knockdown of 
mcircRasGEF1B results in altered expression of a wide array of genes. Pathway 
analysis reveals an overall enrichment of genes involved in cell cycle progression, 
mitotic division, active metabolism, and of particular interest, NF-κB, LPS signaling 
pathways and macrophage activation. These findings expand the inventory of 
functionally characterized circRNAs with a novel RNA species that may play a critical 
role in fine-tuning immune responses during macrophage activation and protecting cells 
against microbial infection.  	
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REGULASI TINDAK BALAS IMUN OLEH RNA BULAT RasGEF1B  
ABSTRAK 
RNA bulat (circRNAs) merupakan salah satu spesis RNA yang dibentuk melalui 
sambat balik ekson linear di dalam transkrip yang mengekodkan protein yang berfungsi. 
Walaupun bidang RNA mencapai banyak kemajuan, ia masih sukar difahami sama ada 
majoriti RNA bulat adalah hasil produk sambilan sambatan dengan fungsi yang tidak 
diketahui, ataupun pembentukan mereka adalah dikawal dari segi masa dan ruang, 
untuk menjalankan fungsi biologi yang tertentu. Setakat ini, majoriti RNA bulat telah 
dikatalogkan di dalam sel rehat. Penyelidikan ini berjaya mengenal pasti RNA bulat 
yang boleh diaruh oleh LPS iaitu mcircRasGEF1B, yang mana kebanyakannya terdapat 
dalam sitoplasma, menunjukkan ekspresi gen yang spesifik kepada sel tertentu, dan 
turut mempunyai suatu homolog manusia dengan sifat-sifat yang serupa iaitu 
hcircRasGEF1B. Selain itu, eksperimen fungsian turut menunjukkan bahawa 
pengurangan ekspresi mcircRasGEF1B turut mengurangkan transkrip ICAM-1 yang 
diaruh oleh LPS. Penyelidikan ini juga telah membuktikan bahawa mcircRasGEF1B 
mengawal kestabilan mRNA ICAM-1 yang matang. Untuk mendapatkan pandangan 
yang lebih luas tentang fungsi mcircRasGEF1B semasa tindak balas selular atas 
rangsangan LPS, pengurangan mcircRasGEF1B dengan pemprosesan tinggi analisis 
transcriptomic telah digabungkan. Keputusan eksperimen menunjukkan bahawa 
pengurangan mcircRasGEF1B menyebabkan pengubahan ekspresi dalam banyak gen. 
Analisis fungsi biologi mendedahkan pengayaan gen yang terlibat dalam perkembangan 
kitaran sel, pembahagian mitosis, metabolisme aktif, dan terutamanya, isyarat NF-κB, 
LPS dan pengaktifan makrophaj. Penemuan ini mengembangkan inventori RNA bulat 
yang telah dicirikan dari segi fungsi, di mana RNA bulat mungkin memainkan peranan 
yang amat penting dalam menala halus tindak balas imun serta untuk melindungi sel-sel 
daripada jangkitan mikrob. 
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CHAPTER 1: INTRODUCTION 
Circular RNAs (circRNAs) are a special class of endogenous non-coding RNAs 
formed by the back-splicing of linear transcripts into a covalently closed circular 
molecule. Although some circRNAs were initially identified decades ago, they were 
long considered to be mere alternative splicing by-products of little biological 
importance (Nigro et al., 1991). The advancement of high-throughput sequencing 
technologies reveals thousands of loci in the human, mouse, and other genomes produce 
circRNAs in a cell-type specific manner. Some of these circRNAs are in fact functional 
(Hansen et al., 2013; Jeck et al., 2013; Memczak et al., 2013; Salzman et al., 2013). The 
functions of circRNAs appear to be mostly manifested via post-transcriptional 
regulatory mechanism, notably as miRNA sponges (Memczak et al., 2013). Despite the 
progress made so far, the number of functionally characterized circRNAs remains very 
low. Thousands of cytoplasmic circRNAs have been identified, with most of them 
having less than three binding sites for a particular miRNA, which undermine their 
regulatory potency as miRNA sponges. Furthermore, most ENCODE experiments have 
been carried out in cell lines under unperturbed conditions, leaving circRNAs expressed 
in many important biological contexts largely unexplored. One of them is the 
transcriptomic response of immune cells following exposure to inflammatory stimuli. 
Understanding the potential regulatory role of circRNAs in immune responses is critical 
for the complete understanding of their regulation and is thus of significant relevance to 
a number of therapeutic contexts, including cancer, heart disease and autoimmunity. 
 In this study, mouse macrophages, RAW264.7 was used to identify circRNAs in 
response to LPS stimulation. With the customized computational pipeline, the candidate 
circRNAs were first shortlisted and verified as bona fide circRNAs. Further 
characterization was performed to assess the cell type specificity, conservation, 
subcellular localization, and translatability of the selected circRNA. With the observed 
2 
inhibitory effect of circRNAs on LPS response genes in TLR4 pathway, the molecular 
mechanism was dissected by investigating the upstream signaling of NF-κB pathway 
and measuring the stability of mature mRNA.  
The study objectives are: 
• To extract candidate circRNAs in respond to inflammatory stimuli (LPS) 
• To verify and characterize LPS-responsive circRNA 
• To elucidate the function of circRNA in regulating immune response 
• To determine the transcriptome-wide effects of circRNA in response to LPS 
treatment 
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CHAPTER 2: LITERATURE REVIEW 
2.1 Overview of circular RNAs (circRNAs) 
The central dogma of molecular biology provides a framework for the flow of 
genetic information. Despite the general notion that DNA is transcribed into RNA and 
RNA is translated into protein, only a small fraction of the human genome (1.5%) 
accounts for protein coding sequence, with the rest of the genome being associated with 
non-coding RNA molecules (Lander et al., 2001). Thus, the majority of RNA is not 
translated. These classes of non-coding RNAs are produced from endogenous 
transcripts with diverse physiological roles and functions. Besides the classical non-
coding RNAs that exist in the form of ribosomal RNA (rRNA) and transfer RNA 
(tRNA), other non-coding RNAs, including microRNAs (miRNA), long non-coding 
RNAs (lncRNAs), piwi-interacting RNAs (piRNAs), small interfering RNAs (siRNAs), 
enhancer RNAs (eRNAs), and small nucleolar RNAs (snoRNAs), have also been 
implicated in mediating core cellular functions. (Gomes et al., 2013; Iwasaki et al., 2015; 
Lam et al., 2014; Morris & Mattick, 2014; Tollervey & Kiss, 1997). A long ignored 
member that recently gains attention in the growing list of non-coding RNA family is 
circular RNAs (circRNAs).  
Though the discovery of circRNAs was demonstrated for at least more than 20 
years ago (Nigro et al., 1991), circRNAs were ignored as artifacts of RNA splicing due 
to several reasons. Firstly, reports suggest that the process of exon shuffling and 
generation of circRNAs are not supported because they are produced from back-splicing, 
which defy the central dogma of mRNA production via linear exons splicing (Figure 
2.1). Secondly, our knowledge on circRNAs remains limited as the detection of circular 
transcripts through traditional RNA analysis is challenging. Unlike other small RNAs 
and miRNAs, circRNAs are hardly separated from other RNA species by size or 
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electrophoresis. Conventional molecular biology tools that require amplification or 
fragmentation strategy will destroy circRNAs. For instance, circRNAs have no free 
ends. Molecular assays that employ polyadenylated RNA or rapid amplification of 
cDNA ends (RACE) enrichment will exclude circRNAs from the downstream analysis 
(Jeck & Sharpless, 2014). Thirdly, circRNAs with back-spliced reads are out-of-order 
on exons arrangement. Standard bioinformatics tools filter out such sequences as 
unmapped reads. Though these complications obscure the detection of circRNAs from 
other gene products, researchers have developed multiple strategies to overcome these 
pitfalls through new bioinformatics algorithms, exonuclease-enriched sample 
preparation, and rRNA depleted high-throughput sequencing. As a result, circRNAs are 
currently being revived as one of the most actively researched non-coding RNAs 
(Figure 2.2).  
 
 
Figure 2.1: Splicing products of exons within a genomic locus. Schematic depiction of 
the exon structure of a linear transcript (right) and a back-spliced circular transcript 
(left). 
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Figure 2.2: Timeline of the discovery of circRNAs. The major findings made from 
1970s to present. The 1970-1980s mark the early observation of circRNAs through 
electron microscopy. The onset of 1990s represents a time period for detection and 
characterization of individual endogenous circRNAs in cells. Post 2010s era indicates 
large-scale detection with high-throughput technologies and functional elucidation of 
circRNAs. 
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2.2 The development of circRNAs as functional non-coding RNAs 
2.2.1 Early evidence of circRNAs 
Early studies of circRNAs stemmed from the electron microscopic studies of 
viral genetic materials, including Sindbis virus (Hsu et al., 1974), tumor virus (Kung et 
al., 1975), Sendai virus (Kolakofsky, 1976), Uukuniemi virus (Hewlett et al., 1977), and 
Hepatitis δ virus (Kos et al., 1986), provided the initial evidence for the existence of 
circRNAs under denatured conditions. It was also suggested that these viral genome 
were circular molecules maintained by base-paring between complementary sequences 
at the 3’ and 5’ ends of linear molecules (Hewlett et al., 1977; Kolakofsky, 1976). 
Besides, a class of plant pathogen with uncoated RNA molecules, known as viroid, was 
also found to harbor covalently closed single stranded RNA molecules (Sanger et al., 
1976). Following the discoveries of viral genome circRNAs, the quest to identify 
circRNAs in eukaryotic cells were first confirmed in the cytoplasm of HeLa cells (Hsu 
& Coca-Prados, 1979), and the yeast mitochondrial RNA (Arnberg et al., 1980). 
However, microscopy approach could not distinguish circRNAs from RNA lariats. For 
example, previous report on yeast circular mitochondrial RNA (Arnberg et al., 1980) 
was later proven to be RNA lariats (Vanderveen et al., 1986).  
It took more than a decade before the first evidence of endogenous circRNAs 
was shown in DCC transcript (28 exons) in human cells (Nigro et al., 1991).  This 
finding described an abnormally spliced transcript with 5’ upstream exons were shuffled 
to 3’ downstream exons using canonical splice sites. The authors reported four 
scrambled exons isolated from cytoplasmic RNAs that were less abundant (one 
thousandth of linear products), non-polyadenylated, and found in both human and 
rodent cells. However, the authors did not observe complementarity between the intron 
sequences adjacent to the exons in this study, which could be responsible for the 
7 
splicing event. In addition, the authors speculated that trans-splicing might contribute to 
the occurrence of scramble exons, yet the hypothesis remained untested.  
The second report on circRNAs partially answered the splicing event. The 
author showed that known ETS-1 shuffled exons occurred in proximal to large introns 
(Cocquerelle et al., 1992). In addition, they also hypothesized that mis-splicing 
mechanism was mainly an intramolecular process. The authors observed mis-spliced 
RNA species in low molecular weight (fractions 2 to 4) in poly A-RNA fractions, 
arguing that multimeric structure did not exist. Furthermore, it was unlikely that 
intermolecular splicing occured between two different ETS-1 transcripts because 
amplification of the back-spliced RNA could not be isolated in high molecular weight 
RNA fractions. The authors further provided evidence that ETS-1 transcript was an 
exonic circRNAs, localized in the cytoplasm, was stable under actinomycin D treatment, 
and utilized canonical splice sites (Cocquerelle et al., 1993).  
The subsequent work on mammalian sex determining gene, SRY, revealed the 
production of exonic circRNAs from the SRY locus in mouse testis (Capel et al., 1993). 
Two pieces of evidence provided support for SRY circularization. First, the 5’ RACE 
experiment failed to identify a start site. Second, RNase H cleavage assay with different 
oligos yielded expected products based on circular SRY (Capel et al., 1993).  
Similar evidence on circRNAs was then continually being reported in different 
human and rat tissues, such as Cytochrome C P-450 2C24 (rat kidney and liver) 
(Zaphiropoulos, 1996), P-450 2C18 (epidermis) (Zaphiropoulos, 1997), ABP (rat testis) 
(Zaphiropoulos, 1997), Dystrophin (brain and skeletal muscle) (Gualandi et al., 2003), 
and AML1 (bone marrow and blood) (Xu et al., 2013). Each discovery began with the 
examination of scrambled exons and observation of back-spliced PCR products. 
Moreover, in each case, these circRNAs were reduced in oligo dT primed RT-PCR 
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samples (Lasda & Parker, 2014). However, the circular transcripts identified were 
generally less abundant than the linear products from the parental genes. Therefore, 
circRNAs were considered as rare events with unclear biological functions before the 
advent of genome-wide sequencing technologies. 
2.2.2 Transcriptome-wide profiling technology in circRNAs discoveries 
The development of genome-wide transcriptome technology has enabled in-
depth characterization of circRNAs in terms of identification, abundance, and putative 
functions. This includes longer read lengths, better algorithms and ribosomal RNA 
(rRNA)-depleted non-polyadenylated RNA sequencing.  
The first genomic approach on circRNAs was carried out with rRNA depletion 
(Ribozero or RiboMinus) strategy. Independent mapping of pair-end reads from 
opposite cDNA ends revealed thousands of exon junctions with opposite order on the 
same gene during gene annotation in multiple cell lines and tissues. The authors relied 
on existing gene annotation to construct candidate circRNAs from pre-existing gene 
models, and did not shortlist circRNAs from unannotated genes (Salzman et al., 2012). 
Validation of several candidates using qPCR revealed that these transcripts were 
predominantly RNase R resistant and non-polyadenylated (Salzman et al., 2012).  
As an extension of this genome-wide method, Memczak et al. (2013) identified 
back-spliced sequence from rRNA-depleted reads from human, mouse, and nematode 
cells. Instead of relying on candidate gene approach, the authors mapped the reads to 
genomic locations de novo. The unmapped reads were then remapped to the two ends of 
a single gene separately to identify back-spliced sequence from individual reads. This 
method provided a better resolution of splice sequence AG/GT in a genomic context. 
The authors showed that many candidate circRNAs were resistant to RNase R, and were 
highly stable. The authors concluded that these back-spliced circRNAs were abundant, 
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stable, conserved, and both tissue- and developmental-specific. Although this method 
enabled identification of unannotated splice sites, it is less sensitive compared to the 
candidate approach.  
Further refinement of the sequencing approach was described in mammalian 
cells by enriching for exonic circRNA with RNase R treatment (CircleSeq) (Jeck et al., 
2013). Since RNase R digestion is a hallmark experiment for the validation of 
circRNAs (Suzuki et al., 2006), the authors compared RNA-seq libraries with and 
without RNase R treatment. This method used MapSplice algorithm on the basis of two 
features (Jeck & Sharpless, 2014) : 1) back-spliced reads were identified as segmented 
reads; 2) Reads from RNase R-treated circRNAs should be at least 8- to 16-fold 
enriched than mock-treated control. The author then generated 3 circle sets: low, 
medium, and high stringency to classify the candidates. Though this method conferred a 
deeper coverage and stringency of circRNAs and RNA lariats, more RNA inputs were 
required for the enrichment procedure before RNA sequencing.   
To further expand the identification and characterization of mammalian 
circRNAs, Guo et al. (2014) developed a “dual alignment” pipeline to identify 
circRNAs and calculated the relative abundance on a large set of non-poly A enriched 
ENCODE data. The authors showed that most circRNAs spanned less than five exons, 
and most of them were expressed in selected cell types with low abundance. In 
comparison with previous circRNAs catalog, the author reasoned that most annotated 
circRNAs were present in only one catalog were due to difference in cell types and 
computational methods. For example, Guo et al. (2014) required circRNAs fraction ≥ 
10, Jeck et al. (2013) required enrichment of circRNA in RNase R samples and 2Mb 
read fusions, while Memczek et al. (2013) required minimum two junction reads per 
circRNA. While raising doubts on the biological functions of most mammalian 
circRNAs, this finding provided a new framework for circRNA investigations. 
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Apart from mammalian cells, numerous genome-wide studies on circRNAs were 
carried out for various purposes in different organisms, as described in archaea (Danan 
et al., 2012), rice (Lu et al., 2015), amoeba (Boesler et al., 2011), human malaria 
parasite (Broadbent et al., 2015), human cell-free saliva (Bahn et al., 2015), human and 
mouse pre-implantation embryos (Dang et al., 2016; Fan et al., 2015). These analyses 
found strong evidence for thousands of circRNAs in various domains of life, suggesting 
that circRNAs may be prevalent with important biological roles.      
2.3 General properties of circRNAs 
There are several key properties of circRNAs. First, circRNAs are stable. Most 
of the circRNAs possess half-life over 48 hours (Jeck et al., 2013), compared to an 
average 10 hours in linear mRNAs (Schwanhausser et al., 2011). Moreover, 
transcriptional block with actinomycin D shows that circRNAs are highly stable after 24 
hours, exceeding the stability of house keeping gene, GAPDH (Memczak et al., 2013). 
Though circRNAs are highly unstable in serum with half-life less than 15 seconds (Jeck 
& Sharpless, 2014), exosome-contained circRNAs are found to be stable in serum at 
room temperature up to 24 hours (Li et al., 2015b). Compare to free circRNAs in serum 
that are susceptible to RNA endonucleases, the higher stability of exosome-circRNAs 
might be due to the protection of exosomes or protein partners (Li et al., 2015b). 
Second, circRNAs are abundant among different species. Bioinformatics 
analysis on human transcriptome study shows evidence of exon scrambling events in 
more than several hundreds of genes, of which the scrambled isoforms are expressed at 
comparable levels to canonical linear isoforms (Salzman et al., 2012). Analysis of 
human (HeLa and H9) cells shows 2748 transcript isoforms, while Drosophila shows 
800 scrambled exon spliced junctions (Salzman et al., 2013; Salzman et al., 2012). In 
addition, a more systematic study reveals approximately 2000 human, 1900 mouse, and 
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700 nematodes circRNAs (Memczak et al., 2013). Moreover, a biochemical-based 
approach with high-throughput RNA-seq from rRNA-depleted, RNase R digested RNA 
pools reveals more than 25,000 distinct back-spliced RNA species in human fibroblast 
(Jeck et al., 2013). A more detailed calculation on circRNAs abundance in human 
tissues shows that one gene produces multiple circRNAs. For instance, a total of 5,955 
host genes yield 20,530 circRNAs (Zheng et al., 2016), and diversity of Alu pairing 
competition leads to alternative circularization from the same gene (Zhang et al., 2014). 
Apart from that, human body fluids also contain circRNAs. For instance, more than 400 
(cell-free saliva) (Bahn et al., 2015), 1000 (serum exosomes) (Li et al., 2015b), and 
4000 circRNAs (peripheral whole blood) (Memczak et al., 2015) have been identified. 
However, an expanded report on ENCODE data shows that 7,112 human circRNAs 
found constitutes of 10% of the transcripts accumulated from their loci, with most of the 
circRNAs are of low abundance. Though some of the expression of circRNAs is low, 
there are exceptions. For example, 90% of the Sry transcripts in adult mouse testis exist 
in circular form (Capel et al., 1993). Additionally, Fmn gene generates around 70 to 80% 
of scrambled transcripts (Chao et al., 1998). In short, one of the challenges is that 
traditional methods in RNA detection that requires free 5’ or 3’ terminal may 
underestimate the abundance of circRNAs. 
Third, circRNAs are predominantly localized in the cytoplasm. The electron 
micrograph from circRNAs extracted from the cytoplasm of HeLa cells provides the 
first indication of the cytoplasmic localization of circRNAs (Hsu & Coca-Prados, 1979). 
The examination of circRNAs using different methods, such as subcellular fractionation 
and in situ hybridization, has reached similar conclusion (Cocquerelle et al., 1993; Jeck 
et al., 2013; Memczak et al., 2013; Nigro et al., 1991; Salzman et al., 2012; Zheng et al., 
2016).  
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Fourth, circRNAs are evolutionary conserved and cell-type specific. Early 
studies showed that there is a substantial conservation of circRNAs in mammals (Jeck 
et al., 2013; Legnini et al., 2017; Memczak et al., 2013). For example, 69 circRNAs in 
murine testis are orthologous to the precise genomic sequence in human circRNAs 
(Jeck et al., 2013). In another study, 40% of the highly expressed human circRNAs 
overlap with mouse circRNAs, in which the genomic location in human is overlapped 
with syntenic region in mouse (Legnini et al., 2017). At the molecular level, it has been 
shown that DNA that encodes circRNAs is more conserved than DNA of flanking 
exons (Rybak-Wolf et al., 2015). On the other hand, reports show that the relative 
abundance of circRNAs varies across tissues. For instance, there is relatively higher 
abundance of circRNAs in neuronal tissues compared to heart, liver, testis, and lung 
(You et al., 2015), consistent with other reports that demonstrated that hundreds of 
circRNAs are expressed at > 10 folds higher than host linear transcripts, especially in 
the brain (Ashwal-Fluss et al., 2014; Rybak-Wolf et al., 2015; Veno et al., 2015; 
Westholm et al., 2014). Another computational report identified distinct circular-splice 
junctions (d.c.j) across different cell lines, including leukemia cell K562 (16,559 d.c.j), 
fetal lung fibroblast cell AG04450 (11,590 d.c.j), and foreskin fibroblast BJ (7,771 
d.c.j).  
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2.4 Biogenesis of circRNAs 
 There are three mechanisms that have been proposed to generate circRNAs, which 
are the direct back-splice, the lariat intermediate, and the RNA binding protein (RBP) 
factors models. 
2.4.1 Direct back-splice model 
Direct back-splicing model refers to the event where downstream splice donor is 
paired with unspliced upstream splice acceptor. The branch point located upstream of 
the circularized exon attacks a downstream splice donor, generating a Y-shaped 
intermediate. Next, the 3’ end of the exon attacks its own 5’ end; ultimately produce a 
circRNA (Figure 2.3A). 
To facilitate the production of circRNAs, sequence specific elements, such as 
flanking introns with inverted or ALU repeats, are required. Various sizes of flanking 
introns contain inverted repeat sequences that base-pair and bring the splice sites in 
close proximity to process circRNAs production via 5’ to 3’ splicing (Ivanov et al., 
2015; Liang & Wilusz, 2014; Zhang et al., 2014). For example, SRY gene contains 
exons flanked by inverted repeats of more than 15 kb surrounding the mouse SRY exons 
that circularize (Capel et al., 1993). Additional experiment shows that a minimum of 
400 complementary nucleotides base-pairing is necessary for SRY circularization 
(Dubin et al., 1995). Liang and coworker mutagenizes circRNAs expression vectors and 
concludes that miniature introns with less than 100 nucleotides containing splice sites 
with 30 to 40 nucleotides inverted repeats are sufficient for circularization (Liang & 
Wilusz, 2014). Collectively, analysis on sequence requirements using mini-genes from 
natural circRNAs and genome-wide computational sequence analysis suggest that 
complementary sequence circRNAs production is associated with ALU repeats (Ivanov 
et al., 2015; Jeck et al., 2013; Zhang et al., 2014).  
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2.4.2 Lariat intermediate model 
Lariat intermediate arises from internal splicing with lariats containing skipped 
exons are produced as a result of exon skipping (Figure 2.3B). For example, exon-
skipping events are consistent with circRNAs production from cytochrome P450 2C24 
gene (Zaphiropoulos, 1996). Furthermore, simple eukaryote genomes are almost devoid 
of repeat sequences. In yeast, it has been shown that lariat structures containing exons 
are a common intermediate before the production of circRNAs (Barrett et al., 2015).  
2.4.3 RNA-binding protein (RBP) factors model 
Both intron pairing and lariat precursor models could not sufficiently explain 
how a single abundant transcript can generate cell- and tissue-specific circRNAs (Jeck 
& Sharpless, 2014; Salzman et al., 2013). Alternative splicing is known to play key 
roles of transcriptional controls in development and physiological responses. Thus, 
tightly regulated alternative splicing event in circRNAs production prompts the 
likelihood of the involvement of RBPs (Figure 2.3C). 
RBPs bind to the flanking introns and the interaction between RBPs bring the 
splice donor and acceptor into close proximity, thereby generating circRNA (Ashwal-
Fluss et al., 2014). For example, the splicing factor muscleblind (MBL) regulates the 
production of its own circMBL from its second exon in both flies and humans. Flanking 
introns bracketing circularized exon of MBL contain conserved MBL binding sites and 
modulation of MBL levels affects circMBL biogenesis (Ashwal-Fluss et al., 2014). In 
addition, Quaking (QKI), which belongs to the STAR family of KH domain-containing 
RBPs, promotes circRNA biogenesis during epithelial and mesenchymal transition 
(Conn et al., 2015). QKI binds to intronic QKI binding motifs and insertion of such 
motifs into linear RNA is sufficient to induce de novo circRNAs formation (Conn et al., 
2015). Lastly, adenosine deaminase acting on RNA (ADAR), a highly conserved RNA-
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editing enzyme, has been implicated in circRNA biogenesis as well. In the absence of 
ADAR1 and ADAR2, the expression of circRNAs is upregulated independently of the 
linear host mRNA expression (Ivanov et al., 2015). It is likely that ADAR blocks the 
base-pairing between intron inverted repeats, thereby preventing circRNAs formation. 
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Figure 2.3: Models of circRNA biogenesis. (A) Direct back-splice model requires ALU 
repeats complementation or intronic reverse complement motifs to bring the donor-
acceptor together, forming a circularized exon. Exon skipping is not required in this 
model; (B) Lariat intermediate model requires exon skipping during canonical linear 
splicing to generate a lariat structure containing circularized exons. (C) RBP factors 
model involves additional proteins to promote circularization, such as QKI, ADAR, and 
MBL. 
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Figure 2.3, continued 
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2.5 Validation tools for circRNAs 
 Divergent primer is used to amplify away from the genomic context, but 
converges when back-spliced sequences bring outer sequence back together. However, 
this method could not rule out tandem DNA duplication and trans-splicing, in which 
both can generate apparent back-splice junction on the same gene. Hence, alternative 
additional tools to assess back-splice sequence are needed. 
Enzymatic methods further strengthen the circularity of a molecule. The 
treatment with RNase R exonuclease (3’ to 5’ exonuclease activity), and tobacco acid 
phosphatase (5’ to 3’ exonuclease activity) degrades linear RNA while preserving 
circRNA. Comparison between mock and enzyme treatment reveals an enrichment of 
circRNAs species relative to linear transcripts. 
A standard or virtual northern blot can be used to assess circRNAs (Jeck et al., 
2013). CircRNAs migrate slower relative to linear RNA products. Gel electrophoresis 
can be used to show circular topology of circRNAs. In 2D gel electrophoresis, 
movement of circRNAs is retarded through highly cross-linked than lesser cross-linked 
gels (Tabak et al., 1988), forming a distinct arc shaped movement, compared to a 
smooth migration by linear RNAs (Jeck & Sharpless, 2014; Matsumoto et al., 1990). 
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2.6 Functions of circRNAs 
2.6.1 MicroRNA sponge  
Accumulating evidence has demonstrated the functional roles of circRNAs in 
different cellular physiologies (Figure 2.4A). CircRNAs have been shown to function as 
microRNA (miRNA) sponges. CircRNAs sequester miRNAs via base-pairing, thus 
keeping miRNAs away from their mRNA targets. The first miRNA sponging activity 
from CDR1-as circRNAs is proven both in vitro and in vivo (Hansen et al., 2013; 
Memczak et al., 2013). Both studies show that CDR1-as is densely bound by AGO and 
harbors 63 seed regions for miR-7. In vitro assay shows that CDR1-as binds to miR-7 
(Hansen et al., 2013). Over-expression of CDR1-as reduces the transcriptional 
repression activity of miR-7, thereby enhances the expression of miR-7 target genes. In 
vivo analysis in zebrafish demonstrates the role of CDR1-as in regulating the activity of 
miR-7 that is crucial for brain development (Memczak et al., 2013). Over-expression of 
CDR1-as mimics the phenotypes of knocking down of miR-7 with morpholinos, in 
which the size of the mid-brain reduces in zebrafish embryo. These findings provide the 
first functional role of circRNAs as a developmental regulator. Similarly, SRY circRNA 
harbors 16 seed sequences for miR-138, binds to AGO2, and reduces gene repression 
activity of miR-138 (Hansen et al., 2013). Though no functional role is described, this 
study supports the hypothesis that some circRNAs are miRNA sponges.  
Following the description of circRNAs as miRNA sponges, numerous circRNAs 
have been implicated to bind disease-related miRNAs, suggesting the involvement of 
circRNAs in disease development. For instance, circ-ITCH sponges miR-7, miR-17, 
and miR-214 in esophageal squamous cell carcinoma (Li et al., 2015a), circ-HRCR 
sponges miR-223 in heart dystrophy (Wang et al., 2016a), circ_0005105 sponges miR-
26a in chondrocyte extracellular matrix (Wu et al., 2017), circ-000203 sponges miR-
20 
26b-5p in cardiac fibroblast (Tang et al., 2017), and circ-ZNF609 sponges miR-150-5p 
in Hirschsprung’s disease (Peng et al., 2017) .   
Nonetheless, genome-wide analysis reveals that miRNA sponging could not be 
widely applied across all circRNAs (Guo et al., 2014; Jeck et al., 2013; Memczak et al., 
2013; You et al., 2015). For example, very few of circRNAs harbor more than 10 seed 
regions for a single miRNA (Jeck et al., 2013). Thus, there is constant exploration in 
understanding the other functional roles of circRNAs. 
2.6.2 Transcriptional regulators  
Besides serving as miRNA sponges, there are reports showing that circRNAs 
function as transcriptional regulators (Figure 2.4B). CircRNAs generated from Fmn are 
essential for limb development. Deletion of back-splice acceptor in the murine shows 
normal limb development but incomplete penetrant renal agenesis. The authors 
postulated that “mRNA trap” functions of circRNAs via sequestering transcriptional 
start site, resulted in a non-coding transcript with reduced Formin protein expression 
(Chao et al., 1998). In addition, a special subclass of circRNAs, exon-intron circRNAs 
(ElciRNAs), associates with RNA polymerase II in human cell. These nuclear localized 
ElciRNAs interact with U1 snRNP and Pol II transcription complex at the promoter of 
their parental genes and regulate the expression of their parental genes (Li et al., 2015c). 
Hence, some circRNAs function as transcriptional regulators that modulate their 
parental gene expression. 
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2.6.3 Platforms for protein interaction 
Previous finding reveals that non-coding RNA control gene expression at both 
the transcription and post-transcriptional levels via physical interaction with RNA 
binding proteins or other non-coding RNAs (Turner et al., 2014). CircRNAs might have 
similar roles in protein interactions to mediate cellular functions (Figure 2.4C). For 
example, circRNAs are associated with AGO2 and RNA Pol II (Jeck et al., 2013; 
Memczak et al., 2013). In addition, similar scenario is also found in circ-Mbl, which 
competes for binding to Mbl protein for the linear splicing (Ashwal-Fluss et al., 2014). 
Besides, circFoxo3 forms a ternary complex with CDK2 and p21, and blocks cell cycle 
progression by arresting CDK2 functions (Du et al., 2016).  
2.6.4 Translational ability of circRNAs 
Several lines of evidence show that introduction of internal ribosome entry site 
(IRES) and reading frames result in translation of engineered circRNAs in vitro (Abe et 
al., 2015; Chen & Sarnow, 1995; Kramer et al., 2015; Wang & Wang, 2015). Thus, it 
raises the possibility that endogenous circRNAs derived from protein coding DNA 
sequence, for example, those with ATG translational start site, could be translated into 
functional proteins (Figure 2.4D). Though polysome profiling shows that majority of 
the circRNAs provides no evidence for translation (Guo et al., 2014; Jeck et al., 2013), 
the first endogenous translational evidence of protein coding circRNA in eukaryotes is 
indicated in circ-ZNF609. The authors demonstrated that circ-ZNF609 contains a start 
codon and with an in frame stop codon created upon circularization. This circRNA 
controls myoblast proliferation, is associated with heavy polysomes, and translated 
through splicing dependent, cap-independent mechanism (Legnini et al., 2017).  
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2.6.5 Disease association 
It has been shown that some circRNAs are associated with human diseases. The 
INK4/ARF locus at chromosome 9p21 is one of the most frequently altered regions in 
human cancers. Besides encoding for cyclin dependent kinase inhibitors p15INK4b, and 
p16INK4, there is a new large antisense non-coding RNA, ANRIL, which is mapped to 
the same locus. Importantly, the expression of a circular variant of ANRIL, circ-ANRIL, 
affects ANRIL splicing and correlates with human atherosclerosis (Burd et al., 2010). In 
addition, has_circ_0001649 was downregulated in hepatocellular carcinoma tissues, 
and its expression was shown to correlate with tumor size and tumor embolus (Qin et al., 
2016). A comparison using circRNA microarray data from T cells isolated from both 
adults and elderly shows that circRNA 100783 is involved in chronic CD28 associated 
CD8 (+) T cell aging, and could serve as a new biomarker (Wang et al., 2015). 
Moreover, a RNA microarray correlation study of circRNAs expression in peripheral 
blood of coronary artery disease (CAD) in 12 CAD patients and 12 control individuals 
suggests that peripheral blood circRNA, has_circ_0124644, can be used as a diagnostic 
biomarker for CAD (Zhao et al., 2017). 
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Figure 2.4: Potential functions of circRNAs. (A) CircRNA harbors miRNAs binding 
sites and serves as miRNA sponges, which indirectly controls gene expression; (B) 
Stable circRNAs function as transcriptional regulator by binding to RNA polymerase II; 
(C) CircRNAs act as protein platforms. RBP (MBL) binds to circRNA to compete with 
linear alternative splicing; Cell cycle proteins bind to circRNAs to strengthen 
p21/CDK2 interaction, blocking cell cycle progression; (D) CircRNA that contains 
ORF and in-frame stop codon is translated into proteins in splicing-dependent, cap-
independent manner.  
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2.7 Databases of circRNAs 
A growing number of over thousands of circRNAs have been identified by 
different groups. Hence, the compilation of circRNAs databases and resources is 
necessary for better navigation. Existing databases include circBase (Glazar et al., 2014), 
CircNet (Liu et al., 2016), Circ2Traits (Ghosal et al., 2013), circPedia (Zhang et al., 
2016), circRNABase (Li et al., 2014b), circInteractome (Dudekula et al., 2016), and 
plant-specific PlantcircBase (Chu et al., 2017) (Table 2.1).  
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Table 2.1: List of available circRNA databases 
Database 
Name 
Types of cells Highlights 
CircBase H. sapiens (hg19) 
M.musculus (mm9) 
C.elegans (ce6) 
L. chalumnae (latCha1) 
L. menadoensis (latCha1) 
D.melanogaster (dm3) 
 
One of the earliest and 
comprehensive databases. 
Custom python scripts can be 
downloaded 
CircNet 464 RNA-seq samples without 
PolyA selection from 26 different 
human tissue samples 
Provides a total of 212,950 
circRNAs 
Provides a total of 34,000 
circRNAs with junction sites >3, 
as highly expressed circRNAs. 
Provides circRNA expression 
profiles across 26 different 
human tissues 
Predicts circRNA-miRNA 
interactions and regulatory 
networks 
Provides genomic annotation of 
circRNAs using integrated 
genome browser 
Circ2Traits Data sources taken from 1953 
predicted human circRNAs 
(Memczak et al., 2013), and 
miR2Disease (174 different 
human disease) (Jiang et al., 2009) 
Measures the likelihood of a 
circRNA and disease 
association, calculated using 
hypergeomtric test, p < 0.01 
Visualizes circRNA-miRNA-
mRNA-lncRNA interactome 
network for individual disease 
Information about disease 
associated SNP in circRNA loci 
CircPedia 31 human 
26 mouse 
30 fly 
12 worm 
Integrative database to annotate 
alternative back-splicing in 
circRNAs across different cell 
lines with circRNA 
characterization pipeline 
CIRCexplorer2 
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Table 2.1, continued 
circRNABase H. sapiens (hg19) 
M.musculus (mm9) 
 
Predicts miRNA-circRNA 
interactions by overlapping 
circRNA sequence with CLIP-
seq peaks from miRNA targets  
circInteractome  109 datasets of RNA binding 
proteins (RBP) and circRNAs for 
RNA binding sites (Glazar et al., 
2014).  
 
Searches RBP binding to a 
circRNA and sequences 
upstream or downstream of 
circRNAs 
Identifies RBPs binding to 
circRNA junctions 
Identifies miRNAs targeting 
circRNAs 
Designs divergent primers and 
siRNAs specific for circRNAs 
PlantcircBase Arabidopsis thalina (TAIR10) 
Hordeum vulgare 
(ASM32608v1.26) 
Oryza sativa (RGAPv7) 
Solanum lycopersicum 
(SL2.40.25) 
Zea mays (AGPv3.22) 
Predicts circRNAs as miRNA 
sponges.  
Provides plant circRNAs with 
related information (sequence, 
host genes, expression, 
experimental validation) 
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2.8 Overview of NF-κB signaling pathway 
Cells respond to external stimuli such as microbial infections, inflammatory 
cytokines, physiological stresses and viral infections, through transmission of signals 
from cell surface or cytosolic receptors to the nucleus. In mammals, Nuclear Factor 
Kappa-B (NF-κB) represents one of the best-studied signaling pathways with tightly 
controlled regulatory mechanism in response to stresses. There are five members of NF-
κB family: RelA (p65), RelB, and c-Rel, and precursor proteins NF-κB1 (p105/p50), 
and NF-κB2 (p100/p52) (Gilmore, 2006). All NF-κB proteins share a Rel homology 
domain, which allows them to bind as dimers to κB sites at the promoters or enhancers 
to activate or repress transcription of hundreds of genes (Hayden & Ghosh, 2004).  
 There are two main NF-κB activation pathways in cells: canonical and non-
canonical pathways (Figure 2.5). The canonical pathway is activated mainly by 
physiological NF-κB stimuli, such as tumor necrosis factor receptor (TNFR), 
interleukin 1 beta (IL-1β), and pathogen associated molecular patterns (PAMPs). In 
resting cells, NF-κB dimers are bound to inhibitory IκBα proteins and sequestered as an 
inactive form in the cytoplasm (Ghosh et al., 1998). The initiation of IκB protein 
degradation is mediated through the upstream IκB kinase complex containing two 
catalytic subunits IKKα and IKKβ, and a regulatory subunit, IKKγ or NEMO. 
Activation of the IKK complex phosphorylates IκBα at two conserved serines (S32 and 
S36) in the N-terminal regulatory domain of IκB. In canonical pathway, it is IKKβ 
subunit that catalyzes the phosphorylation (Brown et al., 1995; Chen et al., 1995; 
DiDonato et al., 1996). Once phosphorylated, IκBα is rapidly polyubiquitinated. 
Ubiquitination of IκBα  involves E2 of the UBC4/5 family (Alkalay et al., 1995; Chen 
et al., 1995; Chen et al., 1996) and the E3 ligase Skp1-Cul1-F-box ligase containing the 
F-box protein βTrCP (SCF-βTrCP) (Jiang & Struhl, 1998; Margottin et al., 1998; 
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Spencer et al., 1999; Winston et al., 1999; Yaron et al., 1998). Subsequently, IκBα  is 
degraded by 26S proteasome, which allows NF-κB to translocate into the nucleus and 
activate a wide array of genes (Hayden & Ghosh, 2004). In contrast, the noncanonical 
pathway is induced primarily by TNF family cytokines, including CD40L, BAFF, and 
LT-β, that lead to the activation of NIK. Activated NIK mediates the phosphorylation of 
IKKα, instead of IKKβ and IKKγ.  Phosphorylated IKKα then phosphorylates p100 at 
the C-terminus. Finally, processing of p100 to mature p52 by ubiquitin-proteasome 
dependent mechanism generates the active p52-RelB heterodimer. The complex then 
translocate into nucleus to turn on the transcription of the target genes (Hayden & 
Ghosh, 2004).  
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Figure 2.5: The canonical and noncanonical NF-κB signaling pathway. (A) In the 
canonical NF-κB pathway, NF-κB is sequestered in the cytoplasm through its 
association with IκBα. Upon stimulation by viruses, proinflammatory cytokines, or toll-
like receptors, IKKβ phosphorylates IκBα,  resulting in the degradation of IκBα via the 
ubiquitin-proteasome system. Freed NF-κB then translocate into the nucleus to activate 
target genes. (B) In the noncanonical NF-κB pathway, stimulation by TNF superfamily 
members (CD40L, LTβR, BAFF/Blys) activates NIK. NIK mediates IKKα 
phosphorylation, which in turn phosphorylates p100. The processing of p100 to mature 
form p52 results in the formation of p52/RelB heterodimer. Translocation of p52/RelB 
into the nucleus activates genes related to the development of the secondary lymphoid 
organs. (TLRs, toll-like receptors; IKK, IκB kinase; TNFα, tumor necrosis factor alpha; 
IL-1β, interleukin-1 beta; CCL5, chemokine (C-C motif) ligand 5; IP10, interferon 
gamma-induced protein 10; ICAM1, intercellular adhesion molecule 1; A20, tumor 
necrosis factor, alpha-induced protein 3; CD40L, CD40 ligand; LT-β, lymphotoxin-β; 
BAFF, B-cell activating factor; NIK, NF-κB-inducing kinase; BLC, B-lymphocyte 
chemoattractant; SLC, secondary lymphoid tissue chemokine; ELC, Epstein-Barr virus-
induced molecule 1 ligand CC chemokine; IRF3, interferon regulatory factor 3). 
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2.9  Toll-like Receptors (TLRs) 
Toll-like receptors (TLR) play an essential role in the innate immune response 
via recognition of PAMPs (Figure 2.5). The Toll protein was first discovered in 
Drosophila and shown to be required for the establishment of dorsal-ventral pattern 
during embryogenesis (Anderson et al., 1985). It was then demonstrated that Toll-
mutant flies were highly susceptible to fungal infection (Lemaitre et al., 1996). This 
finding soon led to the identification of the first human Toll homolog, also known as 
Toll-like receptor 4 (TLR4) (Medzhitov & Horng, 2009). Detailed study on TLR4 
shows that it induces genes involved in immune responses and cells or mice with 
mutation in TLR4 gene are hyporesponsive to lipopolysaccharide (LPS) (Poltorak et al., 
1998). To date, there are 10 and 13 TLR family members in human and mouse, 
respectively. The cytoplasmic portion of all the TLRs exhibits high similarity to 
Toll/IL-1 receptor (TIR) domain, while extracellular region showed unrelated structures. 
This suggests that they recognize specific patterns of microbial components. Genetic 
analysis reveals that, among the TLRs, nucleic acid sensing TLRs (TLR3, 7, 8, and 9) 
localizes within the endosome while the other TLRs locates at the plasma membrane. 
Each TLR has been characterized to specifically recognize specific components of 
pathogens, for instance, TLR1/2 (triacylated lipoprotein), TLR3 (double-stranded RNA), 
TLR4 (lipopolysaccharide/LPS), TLR5 (bacteria flagellin), TLR6/TLR2 (diacyl 
lipopeptides), TLR7 (imidazoquinoline, single stranded RNA), TLR8 (single stranded 
RNA), and TLR9 (umethylated CpG DNA) (Takeda & Akira, 2004) (Figure 2.6). 
Importantly, these TLRs trigger the production of proinflammatory cytokines and 
maturation of antigen presenting cells in the immune system to fight off microbial 
infections (Akira et al., 2006). 
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Figure 2.6: TLRs and ligands. TLR1, 2, 4, 5, and 6 localize to the plasma membrane, 
while TLR3, 7, 8, and 9 resides in endosome. TLR2 is crucial in recognizing microbial 
lipopeptides. TLR2 associates with TLR1 and TLR6 to discriminate the difference 
between triacyl- and diacyl- lipopeptides. TLR4 senses bacterial endotoxin LPS 
whereas TLR5 senses bacterial flagellin. TLR3 is a dsRNA receptor. TLR7 and TLR8 
sense ssRNA, while TLR9 is a CpG DNA receptor. Agonist Pam3CSK4, FLA-ST, Poly 
I:C, R837, and ODN1826 are ligands for TLR1/2, TLR5, TLR3, TLR7, and TLR9 
respectively. 
 
 
 
 
 
 
 
 
 
32 
2.10 LPS/TLR4/NF-κB signaling pathway 
LPS is a structural component on the outer membrane of gram-negative bacteria. 
It consists of three core elements: Lipid A, core oligosaccharide, and an O side chain 
(Raetz & Whitfield, 2002). Lipid A is the key PAMP of LPS, which results in 
TLR4/LPS pathway activation (Beutler, 2000). Upon LPS stimulation, there are two 
LPS activation pathways: myeloid differentiation primary response gene 88 (MyD88)-
dependent (Figure 2.7A) and TIR domain-containing adaptor protein inducing IFNβ 
(TRIF)-dependent pathways (Figure 2.7B). In the MyD88-dependent pathway (Figure 
2.7A), MyD88 recruits IL-1 receptor-associated kinase-4 (IRAK-4). IRAK-4 then 
induces the phosphorylation of IRAK-1. Phosphorylated IRAK-1 recruits tumor-
necrosis-factor-receptor-associated factor 6 (TRAF6) to the receptor complex. TRAF6 
in conjunction with ubiquitin-conjugating enzyme 13 (UBC13), and ubiquitin-
conjugating enzyme E2 variant 1 (UEV1A) promotes the recruitment and activation of 
transforming-growth-factor-beta-activated kinase 1 (TAK1) complex in an 
ubiquitination dependent manner. TAK1 then phosphorylates IKK complex, which 
ultimately phosphorylates IκB. The free NF-κB then translocate to the nucleus to induce 
immune-related genes (Akira & Takeda, 2004).  
In the TRIF-dependent pathway (Figure 2.7B), TRIF recruits TRAF3. TRAF3 
facilitates the activation of TBK1, and IκB kinase-ε (IKKε) (Hacker et al., 2006; 
Oganesyan et al., 2006), which in turn phosphorylates interferon regulatory factor 3 
(IRF3) at the C-terminal region. This phosphorylation allows IRF3 to form a 
homodimer, which translocates into the nucleus and induces target gene expression 
(Kawai & Akira, 2007). 
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Figure 2.7: The TLR4/LPS signaling pathway. (A) TLR4-mediated MyD88- dependent 
NF-κB signaling pathway. MyD88 binds to TLR4 through the cytoplasmic TIR 
domains of TLRs. After LPS stimulation, IRAK-4, IRAK-1, and TRAF6 are recruited 
to form a complex. IRAK-4 phosphorylates IRAK-1. Phosphorylated IRAK-1 and 
TRAF6 dissociates from the complex. TRAF6 interacts with TAK1, TAB1, and TAB2. 
Activated TAK1 phosphorylates IKK complex (IKKα, IKKβ, and IKKγ/NEMO), and 
finally induces NF-κB translocation to activate target genes. (B) TLR4-mediated TRIF-
dependent signaling pathway. TRIF recruits TRAF3, then interacts with TBK1, 
IKKε. These kinases phosphorylates IRF3. Phosphorylated IRF3 dimerizes and 
translocates into nucleus to activate target genes. 
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CHAPTER 3: MATERIALS AND METHODS 
3.1 Antibodies 
Antibodies against HSP90 (sc-8262), IRF3 (sc-15991), p65 (sc-372), IκBα (sc-203), α-
tubulin (sc-8035), SNF2H (sc-13054 X), and ICAM-1 (sc-1511) were purchased from 
Santa Cruz Biotechnology, USA.  
3.2 TLR agonists 
LPS and actinomycin D were purchased from Sigma Aldrich, USA. PAM3CSK4, 
ODN1826, and FLA-ST were purchased from InvivoGen, USA. R837 and IKK 
inhibitor were purchased from Merck, USA. Doxycycline was bought from Fisher 
Scientific, USA, and poly I:C was purchased from Tocris Bioscience, USA. 
3.3 Cell lines and culture conditions 
RAW264.7, MEF, HEK293T and THP-1 cells were purchased from ATCC. RAW264.7 
and THP-1 cells were cultured in Rosewell Park Memorial Institute medium (RPMI) 
while HEK293T and MEF cells were cultured in Dulbecco's Modified Eagle’s Medium 
(DMEM). Both media were supplemented with 10% fetal bovine serum (FBS), 
penicillin G (100 µg/ml), and streptomycin (100 µg/ml). Cells were maintained at 37oC 
with 5% CO2 in a humidified incubator.  
3.4 Plasmids  
An shRNA targeting the exon junction of mcircRasGEF1B containing 11 bases of exon 
4 and 14 bases of exon 2 was subcloned into a PLKO-Tet-Puro vector purchased from 
Addgene. The plasmid was subsequently verified by automated DNA sequencing. The 
shRNA sequences were as described in Table 3.1. 
 
35 
Table 3.1: shRNA sequences used in qPCR analysis 
shRNA oligo Sequences  
shRNA mcircRasGEF1B 
top 
CCGGGTGGCGAGGAGGAAAGTATGCCTCACTC
GAGTGAGGCATACTTTCCTCCTCGCCACTTTTT 
shRNA mcircRasGEF1B 
bottom 
AATTAAAAAGTGGCGAGGAGGAAAGTATGCCT
CACTCGAGTGAGGCATACTTTCCTCCTCGCCAC 
 
Italics: exons of mcircRasGEF1B 
3.5 ASO transfections 
ASOs were synthesized by IDT technologies, and 20 nM of ASOs were transfected into 
RAW264.7 cells with the X-tremeGENE HP DNA (Roche) according to the 
manufacturer's protocol. On day one, 400k cells were seeded and transfected at the 
same time. To maximize knockdown efficiency, ASO transfection was repeated 24 
hours after the initial transfection. The ASOs sequences were listed in Table 3.2. 
Table 3.2: ASO sequences used in qPCR analysis 
List of ASOs Sequences  
Control ASO 
5'   mC*mC*mA*mG*mU*mG*G*C*G*A*G*G*A*G
*G*A*A*A*mG*mU*mA*mU*mG*mC   3' 
mcircRasGEF1B ASO I 
5'   mG*mC*mA*mU*mA*mC*T*T*T*C*C*T*C*C*
T*C*G*C*mC*mA*mC*mU*mG*mG   3' 
mcircRasGEF1B ASO II  
5'   mC*mU*mU*mU*mC*mC*T*C*C*T*C*G*C*C*
A*C*T*G*mG*mC*mC*mA*mU*mC   3' 
 
“*”: phosphorothioate; “m”: 2’ O-methyl 
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3.6 Identification of circular splice junctions 
Except where explicitly stated otherwise, all RNA-seq analyses were carried out using 
custom-written python scripts. Total RNA-seq sequencing reads of each subcellular 
fraction from LPS-stimulated macrophages were downloaded from GEO series 
GSE32916 (Bhatt et al., 2012). The sequences of all possible circular splice junctions 
within the same gene based on annotated exons (the ENSEMBL63 annotation and the 
mm9 version of the mouse genome were used) were compiled, retaining RL15 bp on 
each side of the junctions (equivalent to requiring at minimal length of 15 bp for spliced 
alignment overhangs) where RL is the read length. The circular junction sequences were 
then combined with the sequences of the full-length annotated transcripts and a Bowtie 
index was created, which was used to align reads that do not map to the whole genome 
sequence (Langmead et al., 2009). Candidate circular RNAs were then identified based 
on reads mapping to circular junctions.  
3.7 Quantitative RT-PCR 
On day one, RAW264.7 cells were seeded and transfected with 20 nM of control and 
ASO. After the initial transfection, ASO transfection was repeated 24 hours later. The 
cells were incubated for one more day. On day four, cells were treated with LPS for 2 
hours and harvested for RNA extraction. Total RNA was isolated with the Thermo 
Scientific GeneJET RNA Purification Kit. Complementary DNAs were synthesized 
using M-MuLV reverse transcriptase (New England BioLabs, USA), and Random 
Hexamers (Invitrogen, USA). Quantitative PCR was performed with 2X SYBR Green 
PCR Master mix (Thermo Scientific, USA) and run on a Bio-Rad Connect Real-Time 
PCR System. The relative expression levels of linear mRNAs using a SYBR Green 
assay were normalized to housekeeping gene L32. The qPCR parameter for SYBR 
Green is 95 oC for 3 minutes, followed by 40 cycles of both 95 oC for 2 seconds, and 60 
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oC for 20 seconds. Expression levels of circular RNA were measured using gene 
specific divergent primers using a Taqman assay. The relative expression levels of 
circular versus linear isoforms were normalized to housekeeping gene GAPDH. The 
qPCR parameter for Taqman is 50 oC for 2 minutes, 95 oC for 20 seconds, followed by 
3 steps of 40 cycles at 95 oC for 3 seconds, 59.3 oC for 20 seconds, and 72 oC for 30 
seconds. The sequences of the primers used are listed in Table 3.3.  
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Table 3.3: Primer sequences used in qPCR analysis 
List of primers  Sequences 
mL32/5' AACCCAGAGGCATTGACAAC 
mL32/3' ATTGTGGACCAGGAACTTGC 
mICAM-1/5' TTCACACTGAATGCCAGCTC 
mICAM-1/3' GTCTGCTGAGACCCCTCTTG 
mCcl-5/5' GCTGCTTTGCCTACCTCTCC 
mCcl-5/3' TCGAGTGACAAACACGACTGC 
mTNFα/5' CTACTCCCAGGTTCTCTTCAA 
mTNFα/3' GCAGAGAGGAGGTTGACTTTC 
mU6/5' CTCGCTTCGGCAGCACATATAC 
mU6/3' GGAACGCTTCACGAATTTGCGTG 
pre-ICAM-1/5' CAGATCCTGGAGACGCAGAG 
pre-ICAM-1/3' CATTGGGGTCAGTCAGGTCT 
mature ICAM-1/5' CACGCTACCTCTGCTCCTG 
mature ICAM-1/3' AAGGCTTCTCTGGGATGGAT 
hL32/5' AGCTCCCAAAAATAGACGCAC 
hL32/3' TTCATAGCAGTAGGCACAAAGG 
hIL-1β/5' ACAGATGAAGTGCTCCTTCCA 
hIL-1β/3' GTCGGAGATTCGTAGCTGGAT 
mcircRasGEF1B/5' GTATGACTTCCGGGACGAGA 
mcircRasGEF1B/3' TGTTGGATAAGGGCTTCCAG 
mlinearRasGEF1B/3' GATGTCCCGCTGTATGGAC 
mcircPlcl2/5' CTTGCCGTGTCTCCTCGATT 
mcircPlcl2/3' CGTCCAGCAGAAAATACCGA 
mcircUbe2d2/5' TTGTGTGATCCCAATCCAGA 
mcircUbe2d2/3' TCTAGCCTGCCAATGAAACA 
mcircEtv6/5' TGTTCACACAGTGCCTCGAGC 
mcircEtv6/3' GGGCGTGTATGAAATTCGTT 
mcircLilrb3/5' AGGGGAACCTGGATGCAGAA 
mcircLilrb3/3' GCTGGGTGTCCAGTAGTGTC 
Taqman hcircRasGEF1B/5' TCGGGATGAAAGAATGATGAGA 
Taqman hcircRasGEF1B/3' AAAGGGAGGAGTCTGAGGCATAC 
Taqman hcircRasGEF1B probe CAGTGGCGAAGAGGA 
Taqman mcircRasGEF1B/5' CCGGGACGAGAGAATGATGA 
Taqman mcircRasGEF1B/3' GGACTGGTAGAGGTTTCGGTTG 
Taqman mcircRasGEF1B probe CAGTGGCGAGGAGGA 
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3.8 RNase R exonuclease assay 
Total RNA was purified with Thermo Scientific GeneJET RNA Purification Kit. 
Exonuclease digestion experiment was carried out by incubating 35 µg of purified total 
RNA with or without 15 U of RNase R (Epicentre Biotechnologies) at 37 oC for 30 
minutes. The mock- and RNase R- treated RNA were subsequently purified with the 
Thermo Scientific GeneJET RNA Purification Kit.  
3.9 Subcellular fractionation analysis 
RAW264.7 cells were resuspended in a homogenization buffer (10 mM HEPES, 10 mM 
KCl, 10 mM EDTA, 10 mM EGTA, 1 mM DTT, 1 mM MgCl2, 0.5% NP-40, and 5% 
glycerol). Cells were incubated on ice for 20 minutes and then centrifuged at 4 oC at 
500g for 10 minutes. Supernatants were collected as cytoplasmic fractions while the 
pellets were washed 3 times with the homogenization buffer. Total RNA from both 
cytoplasmic and nuclear fractions were purified with the Thermo Scientific GeneJET 
RNA purification kit. Arbitrary unit was calculated based on the equation:  
Cytoplasm fraction: [1/(input/total RNA)], Cytoplasm+/Nucleus/Nucleus+: 
[2^(Ctcytoplasm-Ctcytoplasm+/nucleus/nucleus+)/(input/total RNA)].  
3.10 Polysome analysis 
Twenty million RAW264.7 cells were seeded and treated with LPS for 2 hours. The 
cells were then treated with 200 µM cycloheximide for 10 minutes to stabilize 
polysome complexes. The cells were lysed with a hypotonic lysis buffer (10 mM Tris, 
pH 7.5; 1.5 mM MgCl2; 10 mM KCl; 0.5 mM DTT; 0.5 mM PMSF; 1X Protease 
Inhibitor) containing 0.1% NP40. The cells were incubated on ice for 30 minutes and 
centrifuged at 800g at 4 oC for 10 minutes. The supernatants were collected as 
cytoplasmic extracts. Cytoplasmic supernatant was loaded onto a continuous sucrose 
gradients 10% to 50% in 400 mM KOAc (pH 7.5), 25 mM HEPES, 15 mM Mg(OAc)2, 
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200 µM cycloheximide and 50 units/mL RNase Inhibitor (NEB). Sucrose gradients 
were centrifuged at 4 oC at 100,000g for 3 hours in a SW41 rotor. Equal volume of 
fractions was collected and total RNA was extracted. The identity of individual 
fractions was confirmed by loading equal volume of eluted RNA samples in an agarose 
gel with ethidium bromide staining to visualize the ribosomal RNAs. Free mRNAs and 
polysome fractions were pooled and reverse transcribed with equal input of RNA. The 
relative abundance of free mRNA and polysomes was determined with the equation:  
free mRNA: [1/(input/total RNA)], polysomes: [2^(Ctpolysome-CtfreemRNA)/(input/total 
RNA)] and presented as 100% stacked graph.  
3.11 Immunoblot analysis 
RAW264.7 cells were pretreated with ASOs (as described in section 3.5) before being 
treated with LPS (100 ng/ml) for 0, 6, 9, and 12 hours. The cells were lysed with 
hypotonic lysis buffer (10 mM Tris, pH 7.5; 1.5 mM MgCl2; 10 mM KCl; 0.5 mM DTT; 
0.5 mM PMSF; 1X Protease Inhibitor) containing 0.1% NP40. The cells were incubated 
on ice for 30 minutes and centrifuged at 800g at 4 oC for 10 minutes. The supernatants 
were collected as cytoplasmic extracts. The nuclear pellets were resuspended in nuclear 
lysis buffer (25 mM Tris, pH 7.5; 420 mM NaCl; 1.5 mM MgCl2; 0.2 mM EDTA; 25% 
Glycerol; 0.5 mM DTT; 0.5 mM PMSF; 1X Protease Inhibitor). The nuclear extracts 
were collected by centrifugation at maximum speed at 4 oC for 10 minutes. Both 
cytoplasmic and nuclear extracts were quantified with Bradford assay and 
immunoblotted. Band intensity was quantified with the ImageLab (Biorad) software. 
3.12 RNA extraction, library preparation, and sequencing 
Total RNA was isolated with the Thermo Scientific GeneJET RNA Purification Kit. 
The RNA samples were checked for quality using Bio-Analyzer 2100 (Agilent 
Technologies, San Diego, CA, USA) and Qubit RNA assay kit (APPENDIX A). Total 
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RNA (1.5 µg) from each sample was used to prepare library using ScriptSeq Complete 
Kit (Epicentre Inc, Madison, WI, USA) according to manufacturer’s protocol. The 
sequencing depth was assessed before data analysis (APPENDIX B)  
3.13 RNA-seq data processing and analysis 
Except where otherwise indicated, all analysis were carried out using custom-written 
Python scripts. 
Paired-end (2x75bp) RNA-seq reads were aligned against the mm9 version of the 
mouse genome using TopHat2 (Kim et al., 2013) (version 2.0.8), run with Bowtie 
(Langmead et al., 2009) (version 0.12.9), and the Ensembl 66 annotation with the 
following parameters: --no-discordant --no-mixed --read-realign-edit-dist 0 --read-edit-
dist 4 --read-mismatches 4 --min-segment-intron 10 --min-coverage-intron 10. Raw 
sequencing reads are available from the Gene Expression Omnibus under GEO 
accession number GSE99811. 
Gene-level quantification in Fragments Per Kilobase per Million mapped fragments 
(FPKM) units was carried out using Cufflink (Trapnell et al., 2012) (version 2.0.2). 
For differential expression analysis, sequencing counts at the gene level were obtained 
using HTSeq (Anders et al., 2015) (version 0.6.1p1). DESeq2 (Love et al., 2014) was 
then used to identify differential expressed genes between different conditions. One of 
the three replicates of unstimulated ASO II treated cells exhibited a globally discordant 
transcriptomic profile, and it was excluded accordingly from the differential expression 
analysis. 
Statistically enriched functional categories of genes were identified using 
FuncAssociate 2.0 (Berriz et al., 2009). 
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3.14 Statistical tests 
All of the statistical tests in this study were calculated using 2 tailed student’s t-test 
(Microsoft Excel) 
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CHAPTER 4: RESULTS 
4.1 Identification of mcircRasGEF1B as a LPS-inducible circRNA 
 As the first step to determine if any circRNAs might regulate the immune 
response, circRNA expressed upon LPS stimulation were catalogued using publicly 
available RNA-seq data from mouse macrophages with annotation-based pipeline 
(Bhatt et al., 2012). With the help of Dr. Marinov, a total of 1,916 circRNAs across 
different subcellular fractions and treatment conditions were successfully identified. 
From there, the predictions were validated by carrying out RT-PCR on 5 circRNA 
candidates of various sizes (APPENDIX C), including mEtv6  (132 nucleotides), 
mLilrb3 (1935 nucleotides), mRasGEF1B  (2423 nucleotides), mPlcl2  (4900 
nucleotides), and mUbe2d2  (7902 nucleotides). 
 To verify the 5 circRNA candidates, total RNA from mouse macrophages 
(RAW264.7) cells with or without LPS stimulation were harvested and the presence of 
circRNAs were measured with 2 approaches. First, circRNA specific PCR amplification 
was conducted using divergent primers and Sanger sequencing to identify the back-
splice junction. Second, to rule out the possibility of trans-splicing and genomic 
rearrangement, RNase R, an exonuclease that degrades linear but not circularized RNA 
molecules was used. As a result, out of the 5 tested circRNA candidates, all of them 
showed back-spliced junction (Figure 4.1A-E), and 4 of them were resistant to RNase R 
(Figure 4.1A, B, D, E), while only 1 of them was inducible after LPS stimulation. 
Therefore, mcircRasGEF1B was identified as a LPS-inducible circRNA (Figure 4.1E), 
which was selected for further characterization in this study. 
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Figure 4.1: Identification of LPS-inducible circRNAs. Chromatograms of Sanger 
sequencing showing the sequence of the back-splice junction (left panels) and total 
RNA from RAW264.7 cells induced with or without LPS for 2 hours subjected to 
RNase R exonuclease assay (right panels) to confirm the circularity of (A) mEtv6; (B) 
mUbe2d2; (C) mLilrb3; (D) mPlcl2; and (E) mRasGEF1B. All experiments were carried 
out in duplicates. (*, p < 0.05; **, p < 0.01). 
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4.2 NF-κB dependent expression of LPS-inducible mcircRasGEF1B  
 After the identification of mcircRasGEF1B as a LPS-inducible circRNA, 
subsequent efforts were focused to study this specific RNA molecule. Mouse 
RasGEF1B contains 14 exons while mcircRasGEF1B is the result of exons 2 to 4 
circularization (Figure 4.2A, APPENDIX C). To gain more detailed insight into the 
expression dynamics of mcircRasGEF1B, RAW264.7 cells were stimulated with LPS 
and its expression was measured at various time points (0, 1, 2, 6, 12, and 24 hours). 
CCL5 is known as one of the robust LPS-responsive genes (Liu et al., 2005). Thus it 
was used as a positive control to check the LPS induction quality. Besides, mouse linear 
RasGEF1B, mlinRasGEF1B, was also shown to be induced by LPS (Andrade et al., 
2010). In this experiment, similar to the mlinRasGEF1B parental gene, mcircRasGEF1B 
was induced as early as 1 hour post LPS stimulation. In addition, mcircRasGEF1B was 
stably expressed up to 12 hours after LPS treatment, while mlinRasGEF1B expression 
was reduced by 50% by that time (Figure 4.2B).  
 LPS stimulation activates NF-κB, which serves as the key transcription factor in 
the TLR4/LPS signaling pathway (Qin et al., 2005). To investigate if LPS-induced 
expression of mcircRasGEF1B is dependent on NF-κB, the NF-κB activation was 
blocked by treating RAW264.7 cells with IKK inhibitor VII at various concentrations 
prior to LPS stimulation. IKK inhibitor VII is a selective ATP competitive inhibitor of 
IKK complex, thereby inhibiting cellular IκBα degradation, and blocking NF-κB 
mediated gene expression (Waelchli et al., 2006). In the presence of 1.5 µM inhibitor, 
induction of CCL5 was reduced by 90% while induction of mcircRasGEF1B was 
reduced by 42% (Figure 4.2C). Increasing IKK VII inhibitor concentration to 2.5 µM 
led to almost complete abolishment of LPS-induced expression of mcircRasGEF1B. 
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These results demonstrate that LPS induces the expression of mlinRasGEF1B and 
mcircRasGEF1B in an NF-κB-dependent manner. 
 
Figure 4.2: LPS-inducible and NF-κB dependent expression of mcircRasGEF1B in 
mouse macrophages. (A) Schematic depiction of the exon structure of linear RasGEF1B 
(right) and the back-splicing circular transcript (left). (B) RAW264.7 cells were treated 
with or without LPS for the indicated time periods. The expression levels of CCL5, 
mlinRasGEF1B and mcircRasGEF1B were measured by qRT-PCR. (C) RAW264.7 
cells were pre-treated with the indicated doses of IKK VII for 1 hour before induction 
with or without LPS for 2 hours. The expression levels of CCL5, mlinRasGEF1B and 
mcircRasGEF1B were measured by qRT-PCR using RNA harvested after 2 hours of 
LPS treatment. All experiments were carried out in duplicates. (*, p < 0.05; **, p < 
0.01). 
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4.3 TLR-mediated expression of mcircRasGEF1B 
 Previous study showed that the linear form of RasGEF1B, mlinRasGEF1B was 
strongly induced by poly I:C, and LPS (stimulating TLR3 and TLR4 respectively), 
while to a lesser extent by ODN CpG DNA and the synthetic triacylated lipopeptide 
Pam3CYS (stimulating TLR9 and TLR1/2 respectively) (Andrade et al., 2010). In 
addition, flagellin stimulates TLR5 while imiquimod (R837) can be used to specifically 
activate TLR7 (Hemmi et al., 2002). To test if mcircRasGEF1B was regulated by TLRs 
other than TLR4, RAW264.7 cells were treated with PAM3CSK4, ODN1826, LPS, 
FLA-ST (flagellin from S. typhimurium), poly I:C and R837. RAW264.7 cells 
responded to all of the stimulants except FLA-ST as evidenced by the induction of 
TNFα (Figure 4.3). Both mlinRasGEF1B and mcircRasGEF1B were robustly induced 
by LPS and ODN CpG DNA, and to a lesser extent by poly I:C and Pam3CSK4 (Figure 
4.3). The results suggest that mcircRasGEF1B and mlinRasGEF1B expression is 
induced through several TLR pathways, including TLR4, TLR9, TLR3 and 
TLR1/TLR2. 
 
Figure 4.3: TLR-mediated mcircRasGEF1B expression. The indicated TLR ligands 
were used to treat RAW264.7 cells for 2 hours. The expression levels of TNFα, 
mlinRasGEF1B, and mcircRasGEF1B were measured by qRT-PCR using RNA 
harvested after 2 hours of ligands treatment. All experiments were carried out in 
duplicates. (*, p < 0.05; **, p < 0.01). 
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4.4 Cell-type specific expression of mcircRasGEF1B 
 An analysis of circRNA expression patterns among 15 expression cell lines by 
the ENCODE consortium highlighted that many circRNAs are cell-type specific 
(Salzman et al., 2013). To examine whether the induction of mcircRasGEF1B is cell-
type specific, mouse embryonic fibroblast (MEF) cells were treated with LPS for 
various time points (0, 1, 2, 6, 12, and 24 hours), and the expression of CCL5, 
mlinRasGEF1B, and mcircRasGEF1B was measured. In this experiment, expression of 
CCL5 was induced in response to LPS stimulation in MEF cells. However, LPS failed 
to induce either mlinRasGEF1B or mcircRasGEF1B in MEF cells. This result implies 
that LPS induces the expression of circRasGEF1B in a cell-type specific manner 
(Figure 4.4). 
 
 
Figure 4.4: Cell-type specific mcircRasGEF1B expression. MEF cells were induced 
with or without LPS for the indicated time periods. The expression levels of CCL5, 
mlinRasGEF1B, and mcircRasGEF1B were measured by qRT-PCR. All experiments 
were carried out in duplicates. (*, p < 0.05; **, p < 0.01). 
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4.5 Evolutionary conserved expression of circRasGEF1B 
Early evidence of conservation in circRNAs was demonstrated in several 
reports (Jeck et al., 2013; Legnini et al., 2017; Memczak et al., 2013). Additionally, it 
was also shown that DNA that encodes circRNAs is more conserved than DNA of 
flanking exons (Rybak-Wolf et al., 2015). To assess the conservation of circRasGEF1B, 
the sequences of human and mouse RasGEF1B were first aligned. Both mouse and 
human RasGEF1B contain 14 exons and exons 2 to 4 share high sequence homology 
with 86% identity (Figure 4.5A APPENDIX C). Divergent primers were then designed 
to detect and study the expression of hcircRasGEF1B in a human macrophage cell line, 
THP-1. The predicted hcircRasGEF1B is detected in these cells (Figure 4.5B). Similar 
to the observation in mouse, expression of hcircRasGEF1B in THP-1 cells is induced 
upon LPS stimulation. IL1β is a positive control for the quality of LPS induction 
(Figure 4.5C). Furthermore, the circularity of hcircRasGEF1B is confirmed using an 
RNase R treatment, to which it was resistant unlike the positive control L32, an 
abundant housekeeping ribosomal transcript and hlinRasGEF1B (Figure 4.5D). Taken 
together, this results show that circRasGEF1B is conserved between human and mouse.  
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Figure 4.5: Evolutionary conserved expression of circRasGEF1B. (A) Schematic 
representation of human RasGEF1B (top) and mouse RasGEF1B (bottom); Sequence 
homology between conserved exons 2, 3, and 4 is highlighted (dashed lines). (B) A 
chromatogram of Sanger sequencing showing the sequence of the back-splicing junction 
of hcircRasGEF1B (exons 2 and 4). (C) Human THP-1 cells were induced with or 
without LPS for 2 hours. The expression levels of IL1β, hlinRasGEF1B and 
hcircRasGEF1B were measured by qRT-PCR. (D) THP-1 cells were induced with or 
without LPS for 2 hours and total RNA was subjected to RNase R treatment to confirm 
the circularity of hcircRasGEF1B. The levels of L32, hlinRasGEF1B and 
hcircRasGEF1B were measured by qRT-PCR. All experiments were carried out in 
duplicates. (*, p < 0.05; **, p < 0.01). 
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4.6 Localization and RNA translatability of mcircRasGEF1B 
 As a first step towards understanding the physiological role of circRasGEF1B, 
its subcellular localization was determined. To this end, RAW264.7 cells were treated 
with LPS for 2 hours and fractionated into nuclear and cytoplasmic fractions. The 
cytoplasmic L32 and nuclear U6 transcripts were used as controls for the purity of 
cytoplasmic and nuclear fractions, respectively. As expected, L32 was predominantly 
enriched in the cytoplasmic fraction while U6 was enriched in the nuclear fraction. 
Intriguingly, mcircRasGEF1B was predominantly localized to the cytoplasm similar to 
mlinRasGEF1B (Figure 4.6A). These results are consistent with previous reports 
showing that majorities of circRNAs are cytoplasmic (Jeck et al., 2013; Salzman et al., 
2012), and suggest that mcircRasGEF1B might play a role in the post-transcriptional 
regulation of gene expression. 
 The mcircRasGEF1B arises from the circularization of exons 2, 3, and 4. The 
translational start site of mlinRasGEF1B resides in exon 2, which is part of 
mcircRasGEF1B. To test if mcircRasGEF1B is being translated into a functional 
protein, free- and polysome-bound mRNAs were isolated by sucrose gradient 
ultracentrifugation. An agarose gel was run to verify separation of 18S, 28S, and 
polysome fractions and earlier fractions  (fractions 1-9) were pooled as free mRNAs 
while remaining fractions (fractions 10-23) as polysomes (Figure 4.6B). The relative 
quantity of linear transcripts (mlinRasGEF1B, A20, TNFα, IP10, IκBα, ICAM-1 and 
GAPDH) and circular transcript (mcircRasGEF1B) were then measured by qRT-PCR. 
Linear products were enriched in the ribosome bound fraction for the genes assayed. 
Circular product, mcircRasGEF1B, however, was highly abundant in the free mRNA 
fraction (Figure 4.6C). This finding is in agreement with other reports that failed to 
identify polysome-bound circRNAs (Guo et al., 2014; Jeck et al., 2013; Salzman et al., 
2012). Taken together, this result shows that cytoplasmic localized AUG-containing 
52 
mcircRasGEF1B did not bound to polysomes, and is not translated. 
 
Figure 4.6: mcircRasGEF1B is predominantly located in cytoplasm and is not 
translated. (A) RAW264.7 cells were induced with or without LPS for 2 hours. Whole 
cell lysates were fractionated into cytoplasmic and nuclear fractions. The levels of L32, 
U6, mlinRasGEF1B, and mcircRasGEF1B in these fractions were measured by qRT-
PCR. All experiments were carried out in duplicates. (*, p < 0.05; **, p < 0.01). (B) 
RAW 264.7 cells were induced with LPS for 2 hours and cytoplasmic supernatant was 
subjected to sucrose gradient centrifugation. Total RNA from each fraction was 
harvested and verified with agarose gel. (C) The levels of linear transcripts 
(mlinRasGEF1B, A20, TNFα, IP10, IκBα, ICAM-1 and GAPDH), and circular 
transcript mcircRasGEF1B, in free mRNA and polysome-bound fractions were 
measured by qRT-PCR (n = 2). 
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4.7 Regulation of the expression of ICAM-1 in the TLR4/LPS signaling 
pathway by mcircRasGEF1B  
To test if mcircRasGEF1B plays a role in regulating the TLR4/LPS pathway, 
loss-of-function assay was employed. The expression of mcircRasGEF1B was knocked 
down using two RNase-H based antisense oligonucleotides (ASOs), ASO I, and II, of 
which both target the back-splice junction of mcircRasGEF1B. A sense-strand version 
of ASO I was used as a control ASO (Figure 4.7A). ASO I, and II specifically knocked 
down the expression of mcircRasGEF1B but had no or little effect on mlinRasGEF1B 
(Figure 4.7B). The effect of mcircRasGEF1B knockdown on LPS target genes was 
examined and it was found that it resulted in reduction of ICAM-1 levels at 2 hours after 
LPS induction. LPS-induced ICAM-1 expression was reduced by 27% in ASO I, and 39% 
in ASO II (Figure 4.7B). A more detailed time course using ASO I transfected cells 
revealed that LPS-induced ICAM-1 expression was reduced by 27% and 30% at 2 hours 
and 6 hours respectively in the absence of mcircRasGEF1B (Figure 4.7C). To minimize 
the possibility that the effect observed with mcircRasGEF1B ASO-mediated silencing 
was caused by an ASO off-target effect, an inducible short hairpin RNA (shRNA) 
targeting the junction of exon 4 and exon 2 of mcircRasGEF1B (Figure 4.7D) was 
constructed. McircRasGEF1B was knocked down by treating stable RAW264.7 cells 
carrying the inducible shRNA transgene with doxycycline for 2 days prior to LPS 
induction. Treating the cells with doxycycline significantly reduced the expression of 
mcircRasGEF1B but not the linear mlinRasGEF1B (Figure 4.7E). Importantly, there 
was a 30% reduction of LPS-induced expression of ICAM-1 in the absence of 
mcircRasGEF1B, which was consistent with the ASO mediated knockdown results 
(Figure 4.7E). To further confirm the effect of ICAM-1 at the protein level, western blot 
in mcircRasGEF1B-deficient cells was conducted. McircRasGEF1B was knocked down 
with ASO I, and ASO II, and treated with LPS for 6, 9, and 12 hours. The reduction of 
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ICAM-1 protein was detected across every time point, suggesting that mcircRasGEF1B 
effect was confirmed in both ICAM-1 mRNA and protein levels (Figure 4.7F). Taken 
together, these data indicate that mcircRasGEF1B positively regulates the expression of 
ICAM-1 in the TLR4/LPS signaling pathway. 
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Figure 4.7: mcircRasGEF1B positively regulates the LPS-induced expression of ICAM-
1. (A) ASO I and II targeting mcircRasGEF1B at the junction of exons 4 and 2. The 
control ASO is in the sense orientation but with the same coordinates as ASO I. (B) 
RAW264.7 cells were transfected with ASO I, ASO II, and control ASO, and induced 
with LPS for 2 hours. The expression levels of ICAM-1, mlinRasGEF1B and 
mcircRasGEF1B were measured by qRT-PCR. (C) RAW264.7 cells were knocked 
down with ASO I or control ASO and induced with LPS for the indicated time periods. 
The expression levels of ICAM-1, mlinRasGEF1B, and mcircRasGEF1B were measured 
by qRT-PCR. (D) Schematic depiction of the inducible shRNA construct targeting the 
back-splice junction of mcircRasGEF1B. (E) A stable RAW264.7 clone carrying the 
shRNA construct was induced with 2.5 µg of Doxycycline for 2 days before treatment 
with or without LPS. The expression levels of ICAM-1, mlinRasGEF1B and 
mcircRasGEF1B were measured by qRT-PCR. (*, p < 0.05; **, p < 0.01). Experiments 
were carried out in duplicates, n=2 (B, C) and triplicates, n=3 (E). (F) RAW264.7 cells 
were knocked down with control ASO, ASO I, and ASO II and then induced with or 
without LPS for the indicated time periods. Whole cell extracts were immunoblotted 
with the indicated antibodies. Intensity of bands was quantified using Image Lab 
(Biorad) software normalized to α-tubulin and shown in relative to 0 minute control 
ASO. (CA: control ASO, AI: ASO I, AII: ASO II). This is a representative data from 3 
independent time course experiments.  
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Figure 4.7, continued 
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4.8 Mechanism: The upstream signal transduction of TLR4/LPS pathway is 
unaffected by mcircRasGEF1B 
In the knockdown assays, decreased mRNA levels of ICAM-1 could be due to a 
variety of mechanisms. In this study, 2 possibilities were considered in which either 
mcircRasGEF1B reduces transcription of ICAM-1 or it reduces stability of ICAM-1 
mRNA. The reduction of the transcription of ICAM-1 could be due to blocking of the 
TLR4 signaling or direct inhibition of transcription by mcircRasGEF1B. First, the 
possibility of knockdown of the expression of mcircRasGEF1B affects the TLR4 
signaling was tested. RAW264.7 cells were transfected with control or 
mcircRasGEF1B-specific ASO I, and cell lysates were fractionated into cytoplasmic 
and nuclear fractions. Since LPS induces the activation of NF-κB and IRF3, the IκBα 
degradation and the nuclear translocation of p65 and IRF3, of which are biochemical 
hallmarks of NF-κB and IRF3 activation respectively (Figure 2.7) were examined. It 
was found that mcircRasGEF1B knockdown led to no obvious differences in the 
degradation of IκBα, nuclear translocation of p65, or IRF3 activation (Figure 4.8). Thus, 
these results imply that mcircRasGEF1B does not regulate the upstream signal 
transduction of TLR4/LPS pathway. 
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Figure 4.8: mcircRasGEF1B does not affect upstream signal transduction of TLR4/LPS 
pathway. RAW264.7 cells were knocked down with ASO I or control ASO, and then 
induced with or without LPS for the indicated time periods. Whole cell extracts were 
fractionated and the fractions were immunoblotted with the indicated antibodies. 
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4.9 Mechanism: Regulation of the stability of ICAM-1 transcript by 
mcircRasGEF1B  
Given that mcircRasGEF1B is enriched in the cytoplasm, it is unlikely that it 
directly regulates transcription in the nucleus. Therefore, whether mcircRasGEF1B 
affects the stability of ICAM-1 transcripts was investigated. First, the stability of ICAM-
1 pre-mRNA and mature mRNA was assessed by quantitative RT-PCR measurements 
after blocking transcription with actinomycin D (ActD) for 1, 2, and 4 hours in the 
presence and absence of ASO I. mRNA stability after 2 hours of LPS induction was 
measured and normalized to that of the relatively stable L32 mRNA. In agreement with 
other reports showing that circRNAs are more stable than linear RNAs (Jeck et al., 2013; 
Memczak et al., 2013), these assays revealed that mcircRasGEF1B is more stable than 
mlinRasGEF1B (Figure 4.9A). Furthermore, as observed before, ASO I specifically 
reduced the expression of mcircRasGEF1B but not mlinRasGEF1B (Figure 4.9A). 
Interestingly, in mcircRasGEF1B-deficient cells, there was a reduction of the levels of 
mature ICAM-1 mRNA but not of its pre-mRNA (Figure 4.9B). More importantly, there 
was a small but reproducible decreases in the stability of mature ICAM-1 mRNA (13% 
at 1 hour, 23% at 2 hours, and 12% at 4 hours post ActD treatment) in 
mcircRasGEF1B-depleted cells (Figure 4.9C). In addition, LPS-induced levels of 
ICAM-1 pre-mRNA were similar between control and mcircRasGEF1B-depleted cells, 
suggesting that mcircRasGEF1B does not affect the transcription of ICAM-1. Taken 
together, the results suggest that mcircRasGEF1B controls LPS-induced ICAM-1 
expression through regulating the stability of its mature mRNA. 
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Figure 4.9: mcircRasGEF1B regulates the stability of ICAM-1 mRNA. (A) RAW264.7 
cells were transfected with ASO I or control ASO, and then treated with LPS for 2 
hours followed by treatment with 1 µg/ml of ActD for the indicated time periods. The 
expression levels of ICAM-1, mlinRasGEF1B and mcircRasGEF1B were measured by 
qRT-PCR. (B) Relative levels of ICAM-1 pre-mRNA and mature mRNA were 
measured relative to the levels of L32’s mRNA. (C) The stability of ICAM-1 pre-
mRNA and mature mRNA measured relative to L32. All experiments were carried out 
in quadruplicates, n=4. (*, p < 0.05; **, p < 0.01). 
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4.10 Mechanism: Model of action 
 A proposed model of action mediated by circRasGEF1B in TLR4/LPS pathway 
is shown in Figure 4.10. LPS stimulates TLR4-mediated NF-κB signaling, which leads 
to the transcription of proteins involved in antimicrobial responses, such as ICAM-1. 
circRasGEF1B stabilizes mature ICAM-1 transcripts, leading to a stable expression of 
ICAM-1 protein and antimicrobial responses. In contrast, circRasGEF1B deficiency 
reduces stable mature ICAM-1 transcripts and therefore its proteins. However, the 
molecular interactions of circRasGEF1B and ICAM-1 mRNA remains to be elucidated. 
 
Figure 4.10: Model of action of circRasGEF1B increases the stability of ICAM-1 in 
TLR4/LPS pathway. 
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4.11 Transcriptome-wide characterization of LPS-induced genes in the presence 
or absence of mcircRasGEF1B 
In this study, a model of mechanism of mcircRasGEF1B reduces the transcript 
and protein levels of LPS-induced ICAM-1 through destabilizing its mature mRNA 
products were described. However, the question of to what extend mcircRasGEF1B is 
an important regulator of the inflammatory network remains open. To address this 
question, the genome-wide gene expression dynamics upon activation of the TLR4/LPS 
pathway in control and mcircRasGEF1B-deficient backgrounds were characterized. To 
determine how knockdown of mcircRasGEF1B alters the transcriptomic profile of 
murine macrophage upon LPS stimulation, the expression of mcircRasGEF1B in 
RAW264.7 cells was knocked down using two different ASOs, ASO I, and II, both of 
them targeting the back-splice junction unique to mcircRasGEF1B (Figure 4.11A). A 
sense-strand version of ASO I was used as a control. Then, RNA-seq experiments were 
carried out after rRNA removal from the total RNA from 3 biological replicates of 
RAW264.7 cells of all 3 (Control, ASO I and ASO II) backgrounds, with and without 
LPS stimulation. Next, reads were mapped to the genome, gene levels were quantified, 
read counts per gene was extracted, and genes differentially expressed upon LPS 
stimulation in each background, and genes differentially expressed between control and 
mcircRasGEF1B-knockdown cells were identified with DESeq2 (Love et al., 2014) 
(Figure 4.11B). Robust knockdown efficiency, with ASO I reduces mcircRasGEF1B 
levels by 76%, and ASO II depletes mcircRasGEF1B by 85% (Figure 4.11C) was 
observed. In agreement with the previous findings, the reduction of ICAM-1 expression 
in both ASO I and ASO II-treated cells was also observed (Figure 4.11D). 
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Figure 4.11: Transcriptome-wide characterization of LPS-induced genes in the 
presence or absence of mcircRasGEF1B. (A) mcircRasGEF1B is produced by the 
RasGEF1B locus in mouse though back-splicing. Antisense oligos (ASO) were 
designed specifically targeting the back-splice junction for the purpose of depleting 
mcircRasGEF1B. (B) RAW264.7 cells were treated with the mcircRasGEF1B targeting 
ASO I, and ASO II oligos as well as with a control oligo, then subjected to LPS 
treatment (n = 3). Gene expression changes were then characterized at the global level 
using RNA-seq, thus identifying the genes and pathways that appear to be regulated by 
mcircRasGEF1B. (C) RAW264.7 cells were transfected with ASO I, ASO II, and 
control ASO, and induced with LPS for 2 hours. The expression of mcircRasGEF1B 
was measured by qRT-PCR. (D) The expression level of ICAM-1 in RNA-seq data (top); 
and qRT-PCR (bottom) was measured relative to L32. Error bars represent the variation 
range of triplicate experiments. (*, p < 0.05; **, p < 0.01). (FPKM: Fragments Per 
Kilobase of transcripts per Million mapped reads) 
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Figure 4.11, continued 
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4.12 Genome-wide expression changes upon mcircRasGEF1B depletion 
To directly examine the role of mcircRasGEF1B in the cellular response to 
TLR4/LPS pathway activation, differentially expressed genes between ASO I-treated, 
ASO II-treated, and control cells upon LPS stimulation where compared. A total of 558 
upregulated and 409 downregulated genes after LPS stimulation in ASO I-treated cells 
relative to control cells were observed (Figure 4.12A and C). The transcriptome profiles 
of ASO II-treated cells were considerably more different, with 1,916 upregulated and 
1,870 downregulated genes (Figure 4.12B and C), again consistent with the higher 
efficiency of ASO II-mediated mcircRasGEF1B knockdown. Furthermore, the LPS-
responsive genes between ASO I- and ASO-II-treated cells were compared, and it 
showed that 166 upregulated and 262 downregulated genes were common to both 
conditions (Figure 4.12D). These results show that perturbation of mcircRasGEF1B 
affects the transcriptional or post-transcriptional regulation of hundreds to thousands of 
genes in response to LPS stimulation. 
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Figure 4.12: Gene expression changes upon mcircRasGEF1B depletion. (A and B) 
Scatter plots show gene expression changes in (A) LPS-stimulated ASO I-treated cells; 
(B) LPS-stimulated ASO II-treated cells; relative to LPS-stimulated control cells. (C) 
Number of differentially expressed genes in ASO I- and ASO II-treated, and LPS-
stimulated cells; (D) Overlap between differentially expressed genes in ASO I- and 
ASO II- treated LPS-stimulated cells. 
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4.13 Genes affected by mcircRasGEF1B depletion are enriched for functional 
categories related to LPS response 
The gene expression analysis revealed that perturbation of mcircRasGEF1B 
affected hundreds of genes after LPS stimulation. Next, in order to understand the 
biological roles of the genes misregulated upon mcircRasGEF1B depletion, 
significantly enriched (p ≤ 0.05 after correcting for multiple hypothesis testing) gene 
ontology (GO) functional categories of genes in the sets of genes up- and 
downregulated relative to control in LPS-stimulated ASO-treated cells were identified 
(Figure 4.13). To do this, the genes up- and downregulated in the ASO II background 
were focused due to the higher magnitude of the effect of ASO II on the macrophage 
transcriptome profile (Figure 4.11C). The GO analysis revealed that genes upregulated 
in mcircRasGEF1B knockdown cells are enriched for categories involved in metabolic 
activity, autophagy, DNA replication and mitotic division, and immune response, 
specifically the regulation of IκB/NFκB signaling and the LPS response pathway. A 
number of coherent functional categories were revealed in the set of downregulated 
genes. This specifically included genes involved in chromatin remodeling, RNA 
splicing, cell adhesion, as well as mitochondrial respiratory function and macrophage 
activation. A more detailed examination of the lists of downregulated genes 
corroborated these global observations. For example, among the top downregulated 
genes was IFNB1, a member of the type I interferons, which play key roles in the 
defense against viral infections and in the innate immune responses to pathogens; 
production of IFNB1 is dependent on the LPS-induced TRIF-dependent pathway 
(Toshchakov et al., 2002). The LPS-mediated activation of RAW264.7 cells is known to 
be associated with the regulation of cell cycle progression (Zhuang & Wogan, 1997), 
and the NF-κB and TLR4/LPS signaling pathways are the mechanism through which 
LPS response is mediated, thus the observations of global misregulation of genes 
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involved in these pathways underscore the functional importance of mcircRasGEF1B 
during LPS response in TLR4 pathway. 
 
 
Figure 4.13: Functional categories enriched among differentially expressed LPS-
induced genes in ASO II-treated cells relative to control cells. Representative enriched 
functional categories are shown for (A) downregulated genes; (B) upregulated genes, 
with the x-axis indicating the statistical significance of the observed enrichment. 
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CHAPTER 5: DISCUSSION 
This study reported a novel LPS-inducible cytoplasmic circular RNA, 
mcircRasGEF1B that modulates the expression of ICAM-1 in response to LPS 
stimulation. Several agonists, TRL1/2, TLR3, TLR4, and TLR9, induce the expression 
of mcircRasGEF1B in RAW264.7 cells but not in MEF cells. These treatments induce 
transcription of RasGEF1B gene, which results in both mlinRasGEF1B, and 
mcircRasGEF1B expression. Biogenesis study also shows that circRNA are generated 
co-transcriptionally and circRNAs can function by competing with linear splicing 
(Ashwal-Fluss et al., 2014). This study also shows the evolutionary conservation of 
circRasGEF1B exons between human and mouse. Furthermore, human and mouse 
circRasGEF1B exhibits similar LPS-induced response properties. Silencing the 
expression of mcircRasGEF1B moderately reduces the mRNA expression and protein 
levels of ICAM-1 upon challenging the cells with LPS. Interestingly, mcircRasGEF1B 
is required for maintaining the stability of the mature mRNA of ICAM-1 in LPS-
activated cells. On a broader scale, transcriptomic analysis underscores the importance 
of mcircRasGEF1B in modulating hundreds of gene expression after LPS induction. 
Taken together, this study highlights a new function of circRNA in TLR4/LPS pathway, 
which further expands the inventory of non-coding RNAs’ role in modulating immune 
response to protect cells against microbial infections. 
The unlikelihood of mcircRasGEF1B as miRNA sponges 
The discoveries of circRNAs as miRNA sponges provide the first line of 
consideration in deciphering circRNAs function. In particular, the description of CDR1-
as and its 63 conserved sites for miR-7 exerts a significant function in mammalian cells 
(Memczak et al., 2013). Likewise, in this study, it is tempting to speculate that 
mcircRasGEF1B could sequester miRNAs targeting ICAM-1. The expression of ICAM-
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1 was shown to be regulated by several miRNAs, including miR-223 (Tabet et al., 
2014), miR-141 (Liu et al., 2015), and miR-296-3p (Liu et al., 2013). However, 
sequence analysis of mcircRasGEF1B does not reveal any enrichment of multiple (≥ 3) 
binding sites for any known miRNAs within mcircRasGEF1B, and more importantly, it 
harbors no binding sites for miR-223, miR-141 and miR-296-3p (data not shown). 
Moreover, these observations are consistent with previous reports by Guo et al. and 
Conn et al. analysis showing that the majority of circRNAs do not act as miRNA 
sponges (Conn et al., 2015; Guo et al., 2014). 
No evidence of mcircRasGEF1B translation 
 After the exclusion of mcircRasGEF1B as miRNA sponge, the focus shifts to 
understand whether majority of the cytosolic circRNAs originates from protein-coding 
DNA sequences could be bound by ribosomes and translated into polypeptides. Early 
reports demonstrated in vitro translation (Chen & Sarnow, 1995) and protein-coding 
abilities of artificial circRNA constructs (Abe et al., 2015; Wang & Wang, 2015). 
However, unlike linear mRNAs, endogenous circRNAs are devoid of 5’ cap and 3’ 
poly-A tail, the key structures required for cap-dependent translational initiation. 
Alternatively, cap-independent translation has been reported for many mRNAs with 
sequences that could act as internal ribosome entry site (IRES) (Gilbert, 2010). In fact, 
evidence from circ-ZNF609 shows that a AUG-containing exon, and an in frame stop 
codon upon circularization is bound by heavy polysomes. The protein-coding circ-
ZNF609 utilizes cap-independent machinery for protein translation (Legnini et al., 
2017). Though mcircRasGEF1B shares the same AUG-containing exon 2 as in 
mlinRasGEF1B, there is no in frame stop codon identified after circularization of the 
exons. Furthermore, sucrose gradient ultracentrifugation showed that mcircRasGEF1B 
is present in free mRNA (light polysome) fractions instead of heavy polysome fractions. 
Thus, it is unlikely that mcircRasGEF1B is being translated. 
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Relative abundance of mcircRasGEF1B in modulating ICAM-1 
Based on the calculation, it was estimated that for every 2580 molecules of 
ICAM-1, there is 1 molecule of mcircRasGEF1B. To possess physiological effects at 
such a low abundant level, mcircRasGEF1B would need to either participate in catalytic 
process or interact specifically with the target molecules. First, only a small number of 
mRNA molecules are needed to participate in the catalytic process of translation, 
resulting in many productions of protein molecules from each mRNA. However, unlike 
mRNA, mcircRasGEF1B is not translated, therefore it rules out this potential effect. 
Second, some low abundance lncRNA are proposed to interact with target molecules 
and modulate the output of a single gene (Ulitsky & Bartel, 2013). This underscores the 
importance of low abundance non-coding RNAs in cellular functions of which 
circRNAs could potentially behave the same way. It has also been noted that, for the cis 
effect, the abundance of individual circRNAs do not need to be high to exert an effect. 
For example, low abundance of ElciRNAs is shown to regulate the transcription of 
more abundance parental genes (Li et al., 2015c). Similarly, despite the low 
mcircRasGEF1B: ICAM-1 ratio, the cell-type specific and dynamic expression of 
mcircRasGEF1B in macrophages suggest that this small population of mcircRasGEF1B 
might exert its function through direct- or indirect binding to ICAM-1 mRNAs in 
cytoplasm. 
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The role of mcircRasGEF1B as a post-transcriptional regulator of ICAM-1 
The biochemical fractionation analysis of cellular RNAs indicates that 
mcircRasGEF1B is predominantly found in the cytoplasm. This result prompted the 
possibility that mcircRasGEF1B might regulate the upstream signaling cascade of 
TLR4 pathway. However, activation of NF-κB and IRF3 is normal in mcircRasGEF1B-
deficient cells upon LPS stimulation. Furthermore, measurements of ICAM-1 pre- and 
mature mRNA levels in control and ASO-transfected cells show that LPS-induced 
transcription of ICAM-1 pre-mRNA is not affected by mcircRasGEF1B. Taken together 
these results suggest that mcircRasGEF1B regulates ICAM-1 at the post-transcriptional 
level. 
The LPS-induced expression of the mature ICAM-1 mRNA is reduced in 
mcircRasGEF1B-deficient cells. A reduction of a mature mRNA could be due to less 
efficient mRNA splicing or a decrease in mRNA stability. The latter possibility was 
favored for the following reasons. First, mRNA splicing takes place in the nucleus 
while mRNA degradation occurs both in the cytoplasm and the nucleus. However, 
mcircRasGEF1B is enriched in the cytoplasm. Nonetheless, there is also a possibility 
that the presence of a small amount of mcircRasGEF1B may affect mRNA splicing in 
the nucleus. Second, if splicing of ICAM-1 is blocked in mcircRasGEF1B-deficient 
cells, ICAM-1 pre-mRNA should accumulate over time, which is not the case. Third, 
treating cells with ActD blocks RNA synthesis but not pre-mRNA splicing. The 
turnover rate of ICAM-1 pre-mRNA is comparable between control and 
mcircRasGEF1B–depleted cells when treated with ActD, suggesting that mRNA 
splicing is unaffected. Finally, a reproducible reduction of the stability of mature 
mRNA of ICAM-1 in mcircRasGEF1B-deficient cells was observed in this experiment. 
Thus, this study suggests that mcircRasGEF1B positively regulates the expression of 
ICAM-1 through modulating the stability of mature mRNA of ICAM-1. Given that 
73 
mcircRasGEF1B is unlikely to function as a classic miRNA sponge, mcircRasGEF1B 
might exert its effects on ICAM-1 expression through a novel, previously unreported 
mechanism, which serves as an exciting subject for future study in non-coding RNA 
functions. 
Significance of ICAM-1 in diseases 
ICAM-1 is an important adhesion molecule that has been studied extensively 
especially on endothelial cells due to its role in leukocyte recruitment to inflamed sites. 
In antigen presenting cells including macrophages, ICAM-1 participates in cell-cell 
interactions during antigen presentation while in other cell types ICAM-1 functions in 
microbial pathogenesis and as a signal transduction molecule (Hubbard & Rothlein, 
2000; Staunton et al., 1989). Physiologically, ICAM-1 is expressed at a low basal level 
(Mukhopadhyay et al., 2014). However, during inflammatory and immune responses, 
ICAM-1 level increases substantially and aberrantly at sites of inflammation 
contributing to a number of inflammation-related diseases and injuries such as 
endotoxin-induced airway disease (Kumasaka et al., 1996; Moreland et al., 2002), and 
asthma, (Mukhopadhyay et al., 2014; Wegner et al., 1990) arthritis, (Seidel et al., 1997), 
ulcerative colitis (Vainer, 2010), and chronic cholangiopathies (Andrade et al., 2010). In 
cancer, ICAM-1 has been mainly implicated in local inflammatory tumor 
microenvironment, (Liou et al., 2015) tumor progression, and metastasis (Hayes & 
Seigel, 2009). The molecular mechanisms underlying the transcriptional regulation of 
ICAM-1 gene has an important implication in term of inflammatory-related diseases.  
Of importance, mcircRasGEF1B-mediated regulation of ICAM-1 indicates that 
circRasGEF1B may have functions in innate immune response such as inflammatory-
related diseases, autoimmunity and cancer. For example, depletion of mcircRasGEF1B 
in tumor-associated macrophage (TAM) may cause these cells to adopt the pro-
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metastasis M2 phenotype as ICAM-1 expression has been reported to suppress the M2 
macrophage polarization in a tumor microenvironment (Yang et al., 2015). Although 
macrophage is used as a model system here, it is tempting to speculate that 
mcircRasGEF1B may also regulate ICAM-1 level in other cell types. In particular, 
ICAM-1 plays a major role in the recruitment of neutrophils and lymphocytes in many 
tissues via leukocyte-endothelial cell bridging, thus mcircRasGEF1B deficiency may 
prevent migration of leukocyte cells to inflammatory sites (Basit et al., 2006; Long, 
2011). In addition, down-regulation of mcircRasGEF1B in cancer cells may also affect 
the cytotoxic T-lymphocytes (CTL)-mediated cytotoxicity due to engagement of LFA-1 
on CTL by ICAM-1 on target cells is essential for T-cell activation and for directing the 
released of cytolytic granules into the tumor cells (Hamai et al., 2008).  
Transcriptome-wide expression changes modulated by mcircRasGEF1B  
In this study, a broad spectrum of genes involved in the cellular response to LPS 
activation whose proper expression dynamics is dependent on the LPS-inducible 
cytoplasmic circular RNA mcircRasGEF1B, were identified. The knockdown of 
mcircRasGEF1B and the effects of its depletion on the transcriptome in resting and 
LPS-stimulated cells were studied. The specificity of LPS transcription response was 
examined by assessing the control cells with and without LPS stimulation (mock) and 
confirmed by most immune-related genes such as IL23α, CXCL10, CCL5, IL6, IL1B 
and IFNB1 by qRT-PCR (APPENDIX D).  
Among the top 50 up-regulated genes upon knockdown of mcircRasGEF1B in 
RAW 264.7 cells (APPENDIX E), some of them have been implicated in LPS, NF-κB 
signaling, and immune responses. For example, TIFAB is a TRAF6 inhibitor that 
controls the dynamic of TLR pathway activation, notably LPS-, but not TNF-induced 
TRAF6 dependent NF-κB activation (Varney et al., 2015). It is mainly expressed in the 
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B cells rather than T cells in the spleen and microinjection of TIFAB in NIH3T3 cells 
inhibits the entry of the cells into the S phase of cell cycle (Matsumura et al., 2009). 
Additionally, CD97 inhibits LPS-induced NF-κB pathway through up-regulation of 
PPART-γ in human primary macrophage (Wang et al., 2016b) while ASB2α regulates 
the cell motility in immature dendritic cells (Lamsoul et al., 2013). Several genes in the 
metabolism process were also up-regulated. For example, GCHFR regulates the 
metabolism of tetrahydrobiopterin, an essential co-factor in nitric oxide 
synthase(Gesierich et al., 2003; Nandi et al., 2008). Furthermore, ER located DAD1 is a 
subunit of oligosaccharyltransferase and is required for N-linked glycosylation 
(Kelleher & Gilmore, 1997; Makishima et al., 1997). Besides, ADC is essential in 
polyamine biosynthesis and seed development in Arabidopsis (Hanfrey et al., 2001; 
Urano et al., 2005). 
Among the top 50 down-regulated genes upon knockdown of mcircRasGEF1B 
in RAW 264.7 cells (APPENDIX F) in the context of macrophage activation, loss of 
MYBPC3 triggers proinflammatory responses in dilated cardiomyopathy and increases 
M1 macrophages activation in mice (Lynch et al., 2017). In fine-tuning immune 
responses and cell cycle process, NEK10 mediates G2/M cell cycle arrest and auto-
activates MEK after UV irradiation to restore cellular homeostasis (Moniz & Stambolic, 
2011). Similarly, upon LPS treatment, CRIP1 alters cytokine IL-2, IL-10 and IL-6 
production (Lanningham-Foster et al., 2002). In addition, it has been shown that 
CXCR2+ neutrophils are recruited by TNFα-activated mesenchymal stromal cells to 
promote breast cancer metastasis (Yu et al., 2017). From the metabolism perspective, 
DOC2A is involved in insulin secretion and glucose uptake(Li et al., 2014a). GPD1 is 
reported to regulate amino acid metabolism during fasting in mice (Sato et al., 2016). 
Moreover, GPD1 also take part in lipid oxidation in the skeletal muscle during exercise 
(Sato et al., 2015). Besides, CAR14 is shown to play key roles in intracellular pH 
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regulation in hippocampal neurons in buffering activity (Svichar et al., 2009).   
 Overall, transcriptomic analysis showed that the depletion of mcircRasGEF1B 
leads to the misregulation of a plethora of genes involved in macrophage activation , 
LPS response signaling, cell cycle progression, cell adhesion and metabolic activity. 
Thus, normal level of mcircRasGEF1B is important for the proper progression of 
macrophage activation and LPS signaling. Further experiments should reveal in detail 
the precise mechanisms through which mcircRasGEF1B exerts its function. 
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CHAPTER 6: CONCLUSION 
CircRNAs is a unique non-coding RNA with prospective biological functions. 
In this study, thousands of circRNAs have been extracted from published RNA-seq data. 
Interestingly, one of the circRNAs, mcircRasGEF1B, was shown to be induced by LPS, 
which marks an exciting feature for further study. The general properties of circRNAs: 
back-splice junction, RNase R resistant, evolutionary conserved, cytoplasmic, and 
untranslated, were fulfilled by mcircRasGEF1B. The highlight is that knockdown of 
mcircRasGEF1B reduces ICAM-1 transcript and protein levels, through regulating 
mature ICAM-1 mRNA stability. Overall, this study demonstrates two key findings. 
First, mcircRasGEF1B functions as a positive post-transcriptional regulator of ICAM-1 
in the TLR4/LPS pathway. Second, functional significance of mcircRasGEF1B 
underscores its important role in immune responses regulation. However, the detail 
molecular mechanism of the interaction between mcircRasGEF1B and mature ICAM-1 
mRNA remains unclear. In addition, the precise mechanism of how mcircRasGEF1B 
exerts its effect requires further validation experiments. 
 Future research direction should focus on the interaction of mcircRasGEF1B 
and ICAM-1 mRNA. The low abundance of mcircRasGEF1B could potentially bind to 
ICAM-1 mRNA for a direct RNA stabilization. Biochemical approach can be employed 
to answer this question. For example, RNA-immunoprecipitation (RIP) assay with 
biotinylated control and mcircRasGEF1B-specific ASO, which are complement to the 
back-splice junction of exon 4 and 2. Both ASOs could be used to pull down the 
mcircRasGEF1B. Enrichment of mcircRasGEF1B and relative abundance of ICAM-1 
mRNA levels can be measured by qRT-PCR. Additional focus should pinpoint the 
precise mechanism of mcircRasGEF1B’s function. This includes validation of the 
differentially expressed genes related to LPS, and macrophage activation to discover 
other key genes involved in the pathway. Last but not least, further efforts can also be 
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focused to elucidate the functions of circRasGEF1B using human macrophages in 
responses to different external stimuli. 
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APPENDIX A 
 
Samples QUBIT (ng/ul) Bioanalzyer RIN 
CONTROL-Rep1 225 9.9 
CONTROL-Rep2 257 10 
CONTROL-Rep3 214 9.8 
CONTROL-LPS-Rep1 303 9.7 
CONTROL-LPS-Rep2 328 10 
CONTROL-LPS-Rep3 273 9.8 
ASO1-Rep1 376 9.8 
ASO1-Rep2 418 9.1 
ASO1-Rep3 328 9.3 
ASO1-LPS-Rep1 385 9.6 
ASO1-LPS-Rep2 382 9.9 
ASO1-LPS-Rep3 360 9.6 
ASO2-Rep1 341 9.6 
ASO2-Rep2 401 9.4 
ASO2-Rep3 326 9.7 
ASO2-LPS-Rep1 403 9.7 
ASO2-LPS-Rep2 363 9.5 
ASO2-LPS-Rep3 433 9.6 
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APPENDIX B 
 
Samples Uniqu UniquSplice Mult MultSplice 
CONTROL-Rep1 4001553 1576031 272043 18472 
CONTROL-Rep2 3981124 1517314 301195 19716 
CONTROL-Rep3 3997278 1481999 393086 22969 
CONTROL-LPS-Rep1 4085432 1590647 397261 23080 
CONTROL-LPS-Rep2 4554974 1686258 410300 24515 
CONTROL-LPS-Rep3 4337367 1512642 352840 20430 
ASO1-Rep1 4525466 1390815 266836 21194 
ASO1-Rep2 4823690 1430735 287056 24248 
ASO1-Rep3 5076425 1289118 273866 17786 
ASO1-LPS-Rep1 4478738 1297073 292012 18822 
ASO1-LPS-Rep2 4234949 1547274 320827 24839 
ASO1-LPS-Rep3 4184707 1290558 265492 17471 
ASO2-Rep1 4876629 1636070 305659 24490 
ASO2-Rep2 4620523 1535349 274289 21648 
ASO2-Rep3 2676301 458594 218918 30156 
ASO2-LPS-Rep1 4213403 1452831 268594 23455 
ASO2-LPS-Rep2 4576848 1576320 283714 22517 
ASO2-LPS-Rep3 4040789 1303825 251539 19734 
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APPENDIX C 
Mouse circular RasGEF1B full sequence 
GAAAGTATGCCTCAGACGCCCCCCTTCTCAGCAATGTTTGACAGCAGTGGCT
ACAACCGAAACCTCTACCAGTCCGCAGAGGACAGCTGTGGAGGCTTGTACT
ACCATGACAACAACCTCCTTTCTGGGTCTCTGGAAGCCCTTATCCAACACTT
GGTACCCAATGTGGATTACTATCCTGAT 
AGGACATACATCTTCACCTTCCTGCTTAGTTCTCGGTTATTCATGCATCCGTA
CGAGCTCATGGCTAAGGTTTGCCACCTGTGTGTTGAGCACCAGCGACTGAGT
GAAGGGGACGGCGATAAG 
AACCAGATGAGAAAAATTGCACCTAAAATCCTTCAGCTCTTGACAGAGTGG
ACAGAAACATTTCCGTATGACTTCCGGGACGAGAGAATGATGAGGAACCTC
AAGGACCTGGCGCACAGGATGGCCAGTGGCGAGGAG 
 
Human circular RasGEF1B full sequence 
GAAAGTATGCCTCAGACTCCTCCCTTTTCAGCAATGTTTGACAGCAGTGGTT
ACAATCGAAACCTCTATCAGTCTGCAGAGGACAGCTGTGGAGGGTTGTATT
ACCATGACAACAACCTCCTCTCTGGATCCCTGGAAGCACTCATCCAGCACTT
AGTACCTAATGTGGATTACTATCCAGAT   
 
AGAACATACATATTTACCTTCCTACTCAGTTCTCGGTTATTTATGCATCCGTA
TGAGCTAATGGCCAAAGTTTGCCACTTATGTGTTGAGCACCAGAGACTAAG
TGATCCTGATAGTGATAAG   
 
AACCAGATGAGAAAAATTGCACCCAAAATCCTTCAACTCCTCACGGAATGG
ACGGAAACATTTCCCTATGATTTTCGGGATGAAAGAATGATGAGAAACTTA
AAAGATCTGGCTCACCGAATAGCCAGTGGCGAAGAG     
 
 
Underline: backsplice junction 
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Mouse predicted circular Etv6 sequence 
 
CAGGAACGAATTTCATACACGCCCCCAGAGAGTCCAGTGGCAAGCCACCGT
TCCTCGACTCCGCTTCATGTTCACACAGTGCCTCGAGCGCTCAGGATGGAGG
AAGACTCGATCCACCTGCCAACACACCTGC 
  
Mouse predicted circular Plcl2 sequence 
 
GATGGCACGAAGCAGAAAAGGGAGCGGAAGAAGACGGTGTCATTCAGCAG
CATGCCGACAGAGAAGAAGATCAGCAGCGCAAGTGACTGTATCAACTCAAT
GGTTGAGGGCTCTGAACTCAAAAAGGTTCGTTCTAACTCCAGAATTTACCAT
CGGTATTTTCTGCTGGACGCCGACATGCAAAGCCTGAGGTGGGAGCCATCT
AAGAAGGATTCTGAGAAAGCCAAGATTGATATCAAATCTATCAAGGAAGTG
AGAACAGGAAAGAACACAGATATATTCCGCAGCAATGGCATTTCTGAGCAG
ATCTCTGAAGATTGTGCATTTTCAGTCATATATGGAGAAAATTATGAGTCAC
TTGATTTGGTTGCCAATTCTGCAGATGTTGCAAACATCTGGGTGACAGGACT
CCGCTACCTGATTTCTTATGGGAAACATACACTTGATATGCTAGAAAGTAGC
CAAGACAACATGAGGACTTCTTGGATTTCACAAATGTTTAGTGAAATTGATG
TAGATGGTCTTGGACATATAACTCTGTGTCATGCTGTCCAGTGTATCAGAAA
CCTCAATCCTGGTCTAAAAACAAGCAAAATTGAGCTTAAGTTCAAAGAATT
GCATAAATCAAAGGACAAAGCTGGTACTGAAATCACAAAGGAGGAATTTAT
TGAGGTCTTTCATGAACTTTGTACTAGACCTGAAATTTACTTCCTTTTAGTTC
AGTTTTCAAGCAATAAAGAATTCCTTGATACCAAGGACCTTATGATGTTTCT
TGAGGCAGAACAGGGTGTAGCACATATCAATGAGGAAATAAGCCTGGAAA
TTATTCACAAATACGAGCCATCCAAAGAAGGCCAGGAAAAGGGCTGGCTCT
CCATAGATGGATTCACTAACTACCTGATGTCACCTGATTGTTACATCTTTGA
TCCGGAACATAAGAAGGTCTGTCAGGATATGAAGCAACCTCTGTCTCATTA
CTTTATAAACTCATCTCATAATACATACTTAATAGAGGATCAGTTCCGGGGT
CCCTCTGACATCACGGGATATATCCGCGCTCTGAAAATGGGTTGCAGGAGC
GTTGAATTAGATGTGTGGGATGGGCCAGATAATGAGCCTGTGATTTACACA
GGCCACACCATGACCTCTCAGATAGTCTTCCGCAGCGTCATCGACATCATTA
ACAAGTACGCGTTCTTTGCTTCTGAGTATCCTCTCATCTTATGTTTAGAAAAC
CACTGCTCTATTAAACAACAGAAGGTGATGGTTCAACACATGAAGAAAATT
TTAGGAGACAAGCTGTATACGACATCACCCAACATGGAGGAATCTTATCTA
CCATCCCCAGATGTCCTGAAAGGGAAAATACTAATCAAAGCAAAGAAGCTG
TCTTCAAATTGCTCCGGCGTGGAAGGGGATGTTACTGATGAGGATGAAGGA
GCAGAAATGTCTCAGAGGATGGGGAAAGAGAATGTGGAACAACCCAACCA
TGTGCCTGTGAAGCGGTTTCAGCTTTGCAAAGAACTGTCCGAGCTGGTCAGC
ATCTGTAAATCCGTCCAGTTCAAGGAGTTTCAGGTGTCGTTTCAGGTGCAGA
AGTACTGGGAAGTGTGCTCCTTTAATGAAGTACTTGCGAGTAAATACGCCA
ATGAGAACCCCGGGGACTTTGTGAATTACAATAAGCGTTTCCTCGCCAGGG
TCTTCCCTAGTCCAATGAGAATTGACTCAAGCAACATGAACCCTCAGGATTT
TTGGAAATGTGGCTGTCAGATTGTAGCCATGAACTTCCAGACTCCAGGGCTG
ATGATGGACCTAAACGTTGGCTGGTTTAGGCAGAATGGAAACTGTGGCTAT
GTTCTTCGACCAGCCATCATGAGGGAAGAAGTCTCCTTCTTCAGTGCCAACA
CCAAGGACTCTGTCCCAGGAGTTTCACCTCAGTTGCTTCACATCAAAATCAT
CAGCGGCCAGAACTTTCCCAAACCCAAAGGGTCGGGTGCCAAAGGTGACGT
GGTGGACCCTTATGTCTATGTGGAAATCCACGGAATTCCTGCCGACTGCGCG
GAGCAAAGGACAAAAACGGTGAACCAGAATGGAGATGCTCCTATTTTTGAC
GAGAGCTTTGAGTTTCAGATTAACCTCCCTGAACTAGCCATGGTGCGCTTTG
TCGTGCTGGACGACGACTACATCGGCGATGAGTTCATCGGCCAGTACACCA
98 
TTCCCTTCGAGTGTTTACAGACGGGCTACCGCCATGTGCCTCTGCAGTCCCT
GACTGGAGAGGTCCTCGCCCACGCTTCTCTGTTCGTCCACGTGGCTATTACT
AACAGGAGAGGGGGAGGGAAGCCTCACAAACGGGGCCTTTCCGTGAGGAA
AGGAAAAAAGTCCCGGGAATATGCCTCTCTGAGAACACTGTGGATTAAAAC
TGTAGACGAGGTGTTCAAGAACGCCCAGCCCCCCATACGGGATGCCACGGA
CCTGAGAGAGAACATGCAG 
 
AATGCAGTGGTGTCGTTCAAAGAGTTGTGTGGCCTCTCCTCCGTGGCCAACC
TCATGCAGTGCATGCTTGCCGTGTCTCCTCGATTCCTGGGGCCTGACAATAA
CCCCCTGGTGGTCTTGAACCTTAGTGAGCCCTACCCCACCATGGAGCTGCAA
GCCATCGTGCCTGAGGTGCTGAAGAAGATTGTAACAACTTATGACATG 
 
 
Mouse predicted Ube2d2 circular sequence 
 
GAATTGAATGACCTGGCTCGAGATCCCCCAGCACAGTGTTCAGCAGGTCCT
GTTGGAGATGATA 
 
TGTTTCATTGGCAGGCTACAATAATGGGGCCA 
 
AATGACAGCCCCTATCAGGGTGGAGTATTTTTCTTGACAATTCATTTCCCAA
CAGATTACCCCTTCAAACCGCCTAAG 
 
GTTGCATTTACAACAAGAATTTATCACCCAAATATTAACAGTAATGGCAGC
ATTTGTCTTGATATTCTACGGTCACAGTGGTCTCCAGCACTAACTATTTCAA
AAG 
 
TACTTTTGTCCATCTGTTCTCTGTTGTGTGATCCCAATCCAGATGATCCTTTA
GTGCCTGAGATTGCTCGGATCTACAAAACAGATAGAGAAAA 
 
Mouse predicted Lilrb3 circular sequence 
 
GACACTACTGGACACCCAGCCTTTTAGCCCAAGCCAGCCCTGTGGTAACTTC
AGGAGGGTATGTCACCCTCCAGTGTGAGTCCTGGCACAACGATCACAAGTT
CATTCTGACTGTAGAAGGACCACAGAAGCTCTCGTGGACACAAGACTCACA
GTATAATTACTCTACAAGGAAGTACCACGCCCTGTTCTCTGTGGGCCCTGTG
ACCCCCAACCAGAGATGGATATGCAGATGTTACAGTTATGACAGGAACAGA
CCATATGTGTGGTCACCTCCAAGTGAATCCGTGGAGCTCCTGGTCTCAG    
 
GTAATCTCCAAAAACCAACCATCAAGGCTGAACCAGGATCTGTGATCACCT
CCAAAAGAGCAATGACCATCTGGTGTCAGGGGAACCTGGATGCAGAAGTAT
ATTTTCTGCATAATGAGAAAAGCCAAAAAACACAGAGCACACAGACCCTAC
AGGAGCCTGGGAACAAGGGCAAGTTCTTCATCCCTTCTGTGACACTACAAC
ATGCAGGGCAATATCGCTGTTATTGTTACGGCTCAGCTGGTTGGTCACAGCC
CAGTGACACCCTGGAGCTGGTGGTGACAG   
 
Underline: backsplice junction 
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APPENDIX D 
 
No. Genes log2FC P-value 
1 Il23a 7.8938 0 
2 Cxcl10 7.8371 0 
3 Il1a 7.7641 0 
4 Gbp5 7.3563 0 
5 Ccl5 7.2981 0 
6 Il6 7.1563 1.21E-156 
7 Ccl22 7.0683 1.51E-138 
8 Csf2 6.7174 0 
9 Gm14047 6.7032 5.00E-135 
10 Cxcl2 6.5618 0 
11 Il1b 6.5494 2.19E-93 
12 Gm8818 6.5230 4.24E-241 
13 F3 6.4279 2.04E-121 
14 Cxcl1 6.4135 5.00E-97 
15 Edn1 6.3663 3.01E-185 
16 Il27 6.3570 1.18E-247 
17 Mir155 6.3131 7.98E-190 
18 Ptgs2 6.3039 0 
19 Sele 6.0683 5.69E-90 
20 Ifnb1 5.8384 2.01E-89 
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APPENDIX E 
Gm13642 Gm10231 Gm16092 Gm4285 Dad1 
Gm17383 Hist2h3b Gm11167 Tmem86a AC027184.1 
Gm7027 Tmc8 Tifab Gm14150 Hist4h4 
Pgam1-ps2 Gm17535 Wdr54 Gm10912 Tuba1a 
Gm10722 Hist1h3a Gm10801 Gm11168 Fbxl8 
Gm3386 Gm7701 Cd97 Rpl18-ps1 Gchfr 
Hist1h4m Gm3550 Gm13456 Atp5g2 4933440N22Rik 
Rpl3-ps2 Asb2 Gm10254 Hist1h2bl Adc 
Gm15649 Rps24-ps3 Abcc10 Grin2d Kif17 
Gm6829 Gm10716 Slc22a18 A730068I03Rik 4930486L24Rik 
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APPENDIX F 
 
Gm889 Gm10012 Gm12312 RP23-164N15.3.1 Gm17477 
Fam71a mt-Rnr1 Gm12879 Cxcr2 snoU2-19 
Mir5105 Rpl38-ps2 Gpd1 Crip1 Matn4 
Mybpc3 Gm9153 Gm12455 A930001C03Rik Sarnp 
Gm8292 Car14 Gm9083 Gm12345 Gm13414 
Gm9104 Gm12960 Rpl31-ps1 Hmgb1-ps2 Nek10 
Rpl35a-ps2 Rpl23a-ps3 Rpgrip1 Gm12197 A330069E16Rik 
SNORA22 
A230083N12
Rik Doc2a Ccdc85b Gm17302 
RP24-
399B3.3.1 Scarna6 Rpl19-ps1 Gm5526 4933430H15Rik 
Gm17334 Gm13135 Tmem44 Gm12112 Gm15396 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
